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Abstract 
Cutaneous leishmaniasis is a vector-borne disease caused by intracellular protozoan 
parasites of the genus Leishmania. C3H mice challenged with L. major develop a polarized 
Thl response and subsequently heal, whereas L. amazonensis challenge leads to chronic 
lesions with high parasite loads. This work demonstrates that infection with L. amazonensis 
creates a population of antigen-responsive, CD44hl CD4+ T cells that proliferate and produce 
IL-2 but do not polarize to an effector phenotype and exhibit limited IFN-y production in 
response to IL-12. CD44hl CD4+ T cells from L. amazonensis-infected mice fail to 
accumulate in culture as compared to cells from L. major-infected mice. Neutralization of 
IL-2 promotes IL-12-mediated enhanced proliferation of CD44hl CD4+ T cells from L. 
amazonensis-infected mice, indicating that IL-2 limits cell accumulation in response to IL-12 
in vitro. Following multiple antigen stimulations, CD44hl CD4+ T cells from L. 
amazonensis-'mfccted mice sustain higher CD25 expression than cells from L. major-infected 
mice, a phenotype regulated by IL-2 and similar to regulatory T cells. To recapitulate 
continual in vitro culture of CD4+ T cells with IL-12 in vivo, multiple doses of IL-12 were 
administered to mice during the first two weeks of L. amazonensis infection. Although mice 
administered IL-12 developed a Thl response early during infection, that response was not 
maintained and the mice failed to heal their infections. IL-12 treatment also failed to 
promote a sustained source of antigen-specific IL-12 from B cells in these mice, indicating 
that the failure of IL-12-treated L. amazonensis-infected mice to heal their infection is not 
due to an inability to mount a Thl response, but rather from a lack of sustained, antigen-
specific IL-12 production from B cells. Together, these results indicate that although CD4+ T 
vi 
cells from L. amazonensis-mfected mice respond to IL-12 by enhancing IFN-y production, 
IL-2 suppresses their ability to enhance proliferation in response to IL-12. We believe this 
incomplete IL-12 responsiveness contributes to the chronicity of L. amazonensis infection. 
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Chapter 1 
Introduction 
Leishmaniasis 
Epidemiology and ecology 
Leishmaniasis is a vector-borne disease caused by intracellular protozoan parasites of 
the genus Leishmania. Leishmaniasis is a burden to both people and mammalian animals; it 
is endemic in 88 countries around the world, including countries in South America, southern 
Europe, Asia and the Middle East (39). Leishmania infection can result in a spectrum of 
diseases from self-limiting to disseminating cutaneous lesions, mucocutaneous lesions or 
fatal visceral disease. The ultimate course of disease is determined by both the species of the 
infecting Leishmania organism and the host's susceptibility (70). The various clinical 
presentations of leishmaniasis can be caused by nearly two dozen distinct Leishmania species 
(35). The yearly incidence of cutaneous leishmaniasis is estimated to be between 1 and 1.5 
million cases and 500,000 cases for visceral leishmaniasis (also known as kala azar, which is 
Hindi for black sickness or fever). An estimated 350 million people around the globe are at 
risk for leishmaniasis with 12 million people currently infected. Dogs and rodents serve as 
the primary reservoirs for maintaining and disseminating Leishmania parasites in endemic 
areas (39). 
While leishmaniasis does not often affect citizens of the United States, it is worth 
noting that cases of leishmaniasis have been reported in military personnel who have served 
in Iraq and other countries in the Middle East where leishmaniasis is endemic (44, 93, 94). 
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Human cutaneous leishmaniasis caused by L. mexicana has been reported in Texas (115), 
and cases of canine visceral leishmaniasis have been reported across the country (43, 52, 160, 
169). 
Leishmaniasis is primarily transmitted via the bite of a female sandfly of the 
Lutzomyia spp. in the New World and the Phlebotomus spp. in the Old World. 
Approximately 30 species of sandflies serve as Leishmania vectors (90). Less conventional 
methods of transmission include syringes, blood transfusion, transplacental spread and organ 
transplantation (33, 95, 121, 141). Leishmania parasites are dimorphic parasites that present 
two principle morphological forms. Found within the intestinal tract of the sandfly vector, 
the promastigote parasite is characterized by a long, slender body (15-30 |im by 2-3 pim) and 
a long, free anterior flagellum. Once the parasite is within parasitophorous vacuoles of 
mammalian macrophages or dendritic cells it transforms into the amastigote stage, which is 
characterized by a round or oval body about 2-6 [xm in diameter with no exterior flagellum 
(35). Upon taking a blood meal from an infected mammal, the parasitized macrophages 
containing the amastigote form of the parasite are ingested. The parasites migrate to the 
midgut of the sandfly where they transform into promastigotes within 12 to 18 hours, attach 
themselves to the gut epithelia via lipophosphoglycan (LPG, a promastigote surface 
molecule) and multiply. Over the course of six to seven days, the promastigotes undergo 
metacyclogenesis, a process by which they become infective to a mammalian host. This 
transition is characterized by different morphological stages as well as a biochemical change 
in LPG structure that allows the promastigotes to detach from the gut and migrate forward 
towards the proboscis of the sandfly (162). When the infected sandfly takes another blood 
meal, the metacyclic promastigotes are inoculated into the skin and infection is initiated in 
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the mammalian host. Once inside either a macrophage or dendritic cell, the parasite enters a 
parasitophorous vacuole, transforms into an amastigote and replicates via binary fission. 
Infection is presumably spread when infected macrophages lyse due to their heavy parasitic 
burden, releasing amastigotes that are taken up by additional macrophages or dendritic cells 
(Figure 1). 
Human leishmaniasis 
Humans infected with Leishmania typically present with disease that is classified as 
cutaneous, mucocutaneous or visceral leishmaniasis. Localized cutaneous leishmaniasis 
(LCL) caused by L. tropica and L. major occurs primarily in the Mediterranean basin of 
Europe and the Middle East. New World Leishmania parasites belonging to either the L. 
braziliensis or L. mexicana complexes are responsible for LCL endemic in Central and South 
America. Patients afflicted with New World LCL usually present with a single primary 
lesion on unclothed parts of the body that are easily bitten by sandflies; patients with Old 
World LCL instead can develop multiple primary lesions in these areas (28). Most Old 
World LCL lesions caused by L. major self-cure within two to four months, while those 
caused by L. tropica take slightly longer. Healing for New World patients is variable, as 
healing after infection with L. mexicana is rapid (three months) but slow after infection with 
L. braziliensis and L. panamensis (125). Diffuse cutaneous leishmaniasis (DCL) is a variant 
of LCL in which lesions are disseminated and resemble lepromatous leprosy. Often caused 
by L. aethiopica in the Old World and L. amazonensis in the New World, DCL typically 
begins as a single primary lesion that metastasizes to other areas of the skin including the 
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Figure 1. Life cycle of Leishmania major infection. Leishmania parasites are transmitted by 
the bites of infected female sandflies, which inject a small number of infectious-stage, 
metacyclic promastigotes into the skin. These forms are opsonized efficiently by serum 
components and taken up by macrophages, where they reside in phagolysosomes and 
transform into replicating amastigotes. Infected macrophages are taken up by sandflies 
during blood feeding; they are lysed in the fly midgut, releasing parasites that transform into 
rapidly dividing, non-infectious-stage promastigotes. These forms undergo a process of 
attachment to the midgut wall, release and anterior migration that is accomplished by their 
differentiation to non-dividing, metacyclic promastigotes that can be transmitted when the 
sandfly takes another blood meal. Figure and legend reprinted by permission from 
Macmillian Publishers Ltd: Nature Reviews Immunology, Sacks, D. and N. Noben-Trauth. 
2(11): 845-58, copyright 2002. 
5 
limbs and face. Post-kala-azar dermal leishmaniasis (PKDL) primarily occurs after infection 
with L. donovani, which is endemic in East Africa and India. Post-kala-azar dermal 
leishmaniasis manifests itself in 20 to 50% of patients recovering from visceral 
leishmaniasis. Most of these lesions heal spontaneously over a few months (28). 
Mucocutaneous leishmaniasis (MCL), most commonly reported in Central and South 
America, results from L. braziliensis or L. panamensis infection. Mucosal dissemination 
occurs in a small percentage of these infections, developing one to five years after cutaneous 
leishmaniasis has healed. The mucosal disease often results in a perforated nasal septum and 
destructive inflammatory lesions that can obstruct the pharynx or larynx and produce 
considerable disfigurement (125). These patients rarely self-cure and treatment is necessary 
(28). 
Kala-azar or visceral leishmaniasis (VL) is a systemic disease caused by 
dissemination of members of the L. donovani complex, including L. donovani and L. 
infantum in the Old World and L. chagasi in the New World. However, L. infantum and L. 
chagasi have been shown to be genetically identical (113). Patients typically present with 
fever, weakness, wasting, anemia, hepatomegaly and splenomegaly, and is fatal if left 
untreated (28, 125). An emerging concern is Leishmania/HlV co-infection, as dually 
infected patients have been reported in 28 countries, including Spain, Italy, France and 
Portugal. In these countries, 25 to 70% of adult cases of VL are associated with HIV 
infection and 1.5 to 9% of patients with AIDS suffer from newly acquired or reactivated VL. 
Co-infection cases are being reported more frequently and it is thought that the number of 
cases will continue to rise due to the urbanization of VL (38). Viscerotropic leishmaniasis is 
a variant of VL caused by L. tropica, a species of Leishmania once thought to only cause 
6 
cutaneous leishmaniasis. Several cases of viscerotropic leishmaniasis were diagnosed in 
soldiers who served in Saudi Arabia during Operation Desert Storm. These individuals 
presented with symptoms that were distinct from typical VL, such as malaise, intermittent 
diarrhea and abdominal pain (109). 
Treatment of the various forms of cutaneous leishmaniasis is intended to accelerate 
parasitological cure, reduce scarring and prevent dissemination or relapse. In contrast, the 
intent of VL treatment is to decrease mortality. Despite the intent, the most efficacious 
chemotherapeutic agent for all forms of leishmaniasis is the pentavalent antimonial 
compound, sodium stibogluconate (trade name Pentostam). In use for over 50 years, this 
compound is thought to inhibit amastigote glycolytic activity and fatty acid oxidation. 
Another pentavalent antimonial compound, meglumine antimoniate (trade name Glucantime) 
is often the drug of choice to treat patients in South America (28). Both Pentostam and 
Glucantime are derivatives of stibonic acid; more specifically, the heavy metal antimony 
(Sb(V)) has been joined via oxygen atoms to the carbon chain of glucose. Although both 
drugs are highly effective, there are multiple disadvantages to treatment, including a 
parenteral mode of administration, long duration of therapy and frequent toxic side-effects 
(70). Recent reports exist of antimonial resistance, particularly in the Bihar State of India 
(182). Patients infected with resistant strains are treated with amphotericin B, a microlide 
antibiotic that is very toxic unless administered in its expensive liposomal form (32). 
Miltefosine may be another viable alternative to antimonial therapy. Originally developed as 
an anti-cancer drug, this alkylphospholipid can be administered orally and has been recently 
approved for use in India, Germany and Columbia. As with amphotericin B, however, cost 
remains a barrier to treatment (125). Undoubtedly, the most desirable method of treating 
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leishmaniasis would be prevention via vaccination. To date, no effective vaccine for 
leishmaniasis exists (181). 
Murine cutaneous leishmaniasis 
L. major and the Thl/Th2 paradigm 
Infection of various inbred strains of mice with L. major is an extensively studied and 
well-characterized animal model of cutaneous leishmaniasis (155, 161). The study of these 
mouse models has generated much knowledge regarding host-pathogen relationships and the 
factors required for a positive disease outcome. Early studies demonstrated that host genetic 
background was critical in determining resistance or susceptibility to infection. Susceptible 
strains of mice (BALB/b, BALB/c, BALB/k and SWR/J) develop large ulcerated lesions that 
do not heal. In contrast, infection of resistant strains of mice (129, A/J, AKR, B10.D2, C3H, 
C57BL/6, C57BL/10, CBA, DBA and NZB) with L. major produces small lesions that 
resolve over time (40, 64, 73, 128). Pioneering studies in this field demonstrated that CD4+ 
T cells were necessary for resistance and that the production of IFN-y in vivo correlated with 
resistance (74, 103, 163). These data correlated with earlier in vitro work indicating that 
interferon gamma (IFN-y) is the critical effector molecule in murine leishmaniasis that 
activates macrophages to kill intracellular parasites (126, 127). 
A more precise role for CD4+ T cells during experimental Leishmania infection was 
discovered in 1986 when Mosmann and Coffman published their groundbreaking work 
describing two distinct CD4+ T cell clones, T helper 1 (Thl) and T helper 2 (Th2) cells. Thl 
cells were found to produce interleukin 2 (IL-2) and IFN-y in response to antigen plus 
antigen-presenting cells (APCs) or stimulation with concanavalin A while Th2 cells 
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produced IL-4 and IL-5 (122). The dual role of these cells in vivo has been best illustrated in 
the mouse model of L. major infection. Using adoptive cell transfer, protection against L. 
major infection was obtained with Thl cells whereas Th2 cells promoted disease (167). 
Additional work demonstrated that resistant mice (C57BL/6) possess high levels of IFN-y 
mRNA in their draining lymph nodes and spleens while susceptible mice (BALB/c) express 
high levels of IL-4 mRNA (68). In vivo depletion of IFN-y caused resistant mice to become 
susceptible to L. major infection while neutralization of IL-4 made susceptible mice resistant 
(18, 68). These initial studies of the Thl/Th2 paradigm during L. major infection have 
provided an important background for many additional studies that have facilitated the 
understanding of T helper cell development. 
As of 2002, more than 6,000 papers had been published on Thl and Th2 cells (102). 
The preceding twenty years of immunologic research have delineated the development of 
these CD4+ T cells, including roles for cell surface receptors, signaling molecules and 
transcription factors. The commitment of a naïve T cell to a Thl phenotype begins when 
IFN-y binds the IFN-y receptor and activates STAT1, a transcription factor that in turn 
induces the expression of the master regulator of Thl differentiation, T-bet (185, 186). T-
bet, a member of the T-box family of transcription factors, can be detected in naïve T cells, 
but its expression is dramatically increased in developing and committed Thl cells (58). 
Szabo et al demonstrated that T-bet expression is necessary for resistance to L. major 
infection, as T-bet knock-out mice fail to heal their infections (186). T-bet is thought to 
further perpetuate Thl development by repressing Th2 cytokine expression (185). Because 
binding of IFN-y to its receptor down-regulates expression of the IFN-y receptor |3 chain, IL-
12 becomes important for perpetuating the Thl phenotype (9). IL-12 is a heterodimer 
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composed of two disulfide-linked subunits designated p35 and p40 (178). The IL-12 
receptor is composed of two chains, IL-12 receptor pi (IL-12R|31) and IL-12RJ32. Each 
subunit alone binds IL-12 with low affinity; co-expression of both subunits is necessary for 
high-affinity IL-12 binding and signaling (29, 30, 150). T-bet can induce expression of the 
IL-12 receptor (32 (IL-12RJ32) subunit and facilitate IL-12 responsiveness in CD4+ T cells (1, 
123, 184). Production of IL-12 by APCs including dendritic cells promotes development of a 
Thl response by binding its receptor and activating the STAT4 signaling pathway to 
perpetuate IFN-y production to influence the differentiation of naïve T cells, thereby closing 
the positive feedback loop associated with Thl development (11, 88, 192). 
Other transcription factors and cytokines are also involved in the establishment and 
maintenance of a Thl response, albeit in varying degrees and stages of the response. 
Expression of the transcription factor Hlx is induced by T-bet and functions to promote 
heritable Thl gene induction and IFN-y production (123, 213). The transcription factor ERM 
is also induced during Thl cell differentiation, specifically by IL-12 (136). The cytokines 
IL-18, IL-23 and IL-27 also have been reported to be involved in promoting a Thl response 
(135,147, 188). 
The commitment of a CD4+ T cell to the Th2 lineage results from IL-4 binding to its 
receptor and subsequent signaling via the STAT6 pathway (170, 187). Th2 cells 
preferentially express certain transcription factors, including c-MAF, which regulates the 
expression of IL-4 (71). Upstream of c-MAF is G AT A3, a transcription factor required for 
the induction and maintenance of the Th2 phenotype (211, 212). Like T-bet, GATA-3 can be 
detected in naïve CD4+ T cells; however, its expression increases significantly only in Th2 
cells (58). GATA-3 induces its own expression via an auto-regulatory loop and promotes 
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transcription of genes encoding Th2 cytokines such as IL-4 and IL-5 via chromatin 
remodeling (98, 137, 211), while decreasing IFN-y production and IL-12 responsiveness (46, 
138, 195). Other molecules implicated in Th2 development include the transcription factor 
MEL 18 (91), the post-transcriptional regulators FOGl (friend of GATAI) (214) and ROG 
(repressor of GATA) (117) and possibly the Tec family tyrosine kinase Itk (119). 
The cell-mediated immune response to L. amazonensis 
Infection of L. major-resistant mice with certain New World species of Leishmania, 
particularly L. amazonensis and L. mexicana, creates a very different disease outcome than 
does infection with L. major. As discussed previously, C57BL/6 and C3H mice heal a L. 
major infection; however, these mice develop chronic disease when infected with either L. 
amazonensis or L. mexicana. These vast differences in disease outcome can be partially 
explained by evolution. Based on comparisons of DNA sequences, a divergence between the 
Leishmania complexes L. major, L. mexicana (of which L. amazonensis is a member) and L. 
donovani is estimated to have occurred between 40 to 80 million years ago (116). This is 
similar to the divergence observed between mice and humans. Old World and New World 
species which both cause cutaneous disease are as different from one another as they are 
from species causing visceral disease (116). In addition to evolutionary differences, 
considerable differences in virulence factors also exist between L. major and New World 
species. Lipophosphoglycan (LPG), a complex glycophosphatidylinositol-anchored 
phosphoglycan molecule found on the surface of all Leishmania promastigotes, is known 
virulence factor for L. major but not for L. mexicana (76, 175). In contrast, the cathepsin L-
like cysteine protease B enzymes are considered virulence factors for the L. mexicana 
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complex but not for L. major parasites (4, 34, 36). The metalloprotease gp63 has been 
identified to be important for both L. major and L. amazonensis virulence (85, 168). 
Just as BALB/c mice are susceptible to L. major infection, they, too, are susceptible 
to L. amazonensis infection, developing progressive, ulcerative lesions and systemic disease. 
Initially, infection of BALB/c mice with L. major results in production of both IFN-y and IL-
4. A polarized Th2 response eventually prevails, mediated by a predominance of V|34+Va8+ 
CD4+ T cells which recognize LACK (Leishmania homolog of receptors for activated C 
kinase) antigen and produce IL-4 (86, 156, 173). In contrast, L. amazonensis-infected 
BALB/c mice maintain similar percentages of IFN-y- and IL-4-producing CD4+ T cells 
throughout infection rather than developing a polarized Th2 response and fail to develop 
skewed T cell receptor usage among CD4+ T cells (80). The predominant cytokine produced 
by these mice is IL-2 rather than IFN-y or IL-4. Adoptive transfer of a Th2 cell line to 
BALB/c mice subsequently infected with L. amazonensis exacerbated disease based on 
lesion size and parasite burden, indicating that a polarized Th2 response negatively 
influences disease outcome (80). Additional studies aimed at determining the mechanism by 
which BALB/c mice are susceptible to L. amazonensis infection included administering IFN-
y and genetic deletion of IL-10—neither of which changed disease outcome (16, 140). 
Administration of either anti-IL-4 or anti-TGF-|3 has been reported to heal L. amazonensis-
infected BALB/c mice, but these mice still exhibited lesions and detectable parasites (2, 15), 
suggesting that the susceptibility of BALB/c mice to L. amazonensis is mediated via 
mechanisms other than the development of a polarized Th2 response. 
Rather than developing a progressive, ulcerative lesion as BALB/c mice infected with 
L. amazonensis do, L. major-resistant mouse strains (C57BL/6 and C3H) develop 
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comparatively smaller lesions that may or may not ulcerate. These lesions gradually increase 
in size during the first eight weeks post-infection and then plateau and maintain a relatively 
consistent size for several months. Ample evidence exists that the failure of these mice to 
heal their infections is not due to the presence of a Th2 response, but rather to the failure to 
mount an efficient Thl response. Low to undetectable levels of both IFN-y and IL-4 are 
found during in vitro recall responses of lymph node cells draining the site of L. amazonensis 
infection (2, 83). The poor Thl response associated with L. amazonensis infection persists 
even in the absence of IL-4 or IL-10 (2, 82, 83). Mice that have been treated with anti-IL-4 
antibody or are IL-4 deficient do not heal their infections or enhance IFN-y production (2, 
83). Administration of exogenous IL-12 to IL-4 knockout mice at the time of L. amazonensis 
infection also fails to promote healing (83). In the absence of IL-10, L. amazonensis-infected 
C57BL/6 mice do exhibit a slightly enhanced Thl response, but it is not sufficient to resolve 
the infection, as there is only a modest reduction in the parasite burden of the IL-10 knockout 
mice and no significant difference in lesion size as compared to the wild-type mice (81, 82). 
IL-12 production has been shown to be limited during L. amazonensis infection (83, 152, 
198). Attempts to promote healing by administration of exogenous IL-12 at the time of L. 
amazonensis infection have proven unsuccessful; a phenomenon initially attributed to the 
low level of IL-12R(32 expression on CD4+ T cells (83). More recent research has shown 
that mice chronically infected with L. amazonensis can upregulate both IL-12R|32 and T-bet 
mRNA expression after repeated administration of antigen-pulsed bone marrow-derived 
dendritic cells in the presence of IL-12 (198). These mice subsequently develop a population 
of Thl CD4+ T cells but still exhibit impaired antigen-specific IFN-y production and fail to 
reduce their parasite burden. Additional work has shown that the transfer of a Thl cell line 
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prior to L. amazonensis infection offered some protection against a promastigote infection, 
but not an amastigote infection (151). Together, these results suggest that simply the 
development of a population of Thl CD4+ T cells is not sufficient to heal a L. amazonensis 
infection; it is instead likely that appropriate dendritic cell functions including efficient IL-12 
production must also be established in order to facilitate healing. 
The biology of IL-12 
IL-12 was first identified as a product of Epstein-Barr virus-transformed human B 
cell lines that could activate natural killer (NK) cells and induce IFN-y production and T cell 
proliferation (92). IL-12 is a heterodimer composed of two disulfide-linked subunits 
designated p35 and p40 (178). The genes encoding these two subunits are not located on the 
same chromosome in either humans or mice, but when both genes are coordinately expressed 
within a cell, biologically active IL-12p70 is secreted (63, 206). In addition to dimerizing 
with the p35 subunit, p40 subunits can also form disulfide-linked homodimers (IL-12p40i) 
(54, 104). While the exact biological function of IL-12p402 is uncertain, it may function as 
an antagonist that binds to the IL-12 receptor, thereby preventing binding and signaling of 
IL-12p70 (53, 54, 104). 
The major cellular sources of IL-12 are dendritic cells and macrophages (193). The 
initial production of IL-12 is a rapid process that occurs upon cellular recognition of 
pathogen associated molecular patterns (PAMPs) via Toll-like receptors (TLRs) (108). 
Products from microorganisms, including bacteria, intracellular parasites, fungi, double-
stranded RNA, bacterial DNA and CpG-containing oligonucleotides are all considered 
PAMPs. Toll-like receptor ligands are not sufficient to induce efficient IL-12 production 
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alone ; secondary signals including cytokines and direct cell-cell interactions are necessary as 
well (66, 108). IFN-y enhances IL-12 production, creating a positive feedback loop during 
inflammatory Thl responses. Additionally, continued production of IL-12 is necessary to 
prevent the loss of Thl cells and maintaining a productive Thl response (143, 144, 179). 
Priming of dendritic cells and macrophages with a bacterial stimulus also induces expression 
of CD40 and makes these cells responsive to interactions with the ligand for CD40 (CD40L) 
on activated T cells (164). Signals transduced via CD40 in turn enhance IL-12 production by 
inducing transcription of the genes encoding p35 and p40 (164). IL-12 is a powerful pro­
inflammatory cytokine and mechanisms to regulate it are necessary to prevent immune-
mediated pathological damage associated with an excessive inflammatory response. IL-10 
potently inhibits IL-12 by blocking transcription of both p35 and p40 (7). Transforming 
growth factor-13 (TGF-|3) also negatively regulates IL-12 production by reducing IL-12p40 
mRNA stability (41). IL-12 production is also inhibited by IFN-a, IFN-|3 and tumor necrosis 
factor alpha (TNF-a) and certain G protein-coupled receptors (22, 31, 108). 
IL-12 signaling 
The IL-12 receptor is composed of two chains, IL-12 receptor (31 (IL-12R|31) and IL-
12R|32, and is organized as a dimer on the surface of the cell. Each subunit alone binds IL-
12 with low affinity; co-expression of both subunits is necessary for high-affinity IL-12 
binding (29, 30, 150). IL-12p40 interacts predominantly with the (31 subunit whereas IL-
12p35 interacts primarily with the (32 subunit (150). Activated T and NK cells are the cell 
types that primarily express the IL-12 receptor. Expression of the IL-12 receptor is highly 
regulated on T cells; resting T cells do not express either subunit of the receptor, but 
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expression of both (31 and (32 chains are induced upon T cell activation (37). IL-12RJ32 
expression facilitates IL-12 responsiveness, which is central to establishing an optimal Thl 
response. Thl cells express both subunits of the IL-12 receptor; in contrast, Th2 cells fail to 
express IL-12R|32 (184). 
The IL-12 receptor subunits lack intrinsic enzymatic activity; signal transduction is 
instead accomplished via two members of the Janus kinase family of tyrosine kinases, Jak2 
and Tyk2 (133). Tyk2 associates with the pi subunit and Jak2 binds the (32 subunit of the 
IL-12 receptor (10, 215). The (32 subunit appears to be the signal-transducing component of 
the high-affinity receptor complex, as it contains multiple tyrosine residues on its 
cytoplasmic domain (150). IL-12R|31 is thought to be more important for ligand binding 
rather than signaling because it possesses no intracellular tyrosine residues to initiate a 
signaling cascade (207). Upon ligand binding, the receptor-associated Jaks are activated via 
transphosphorylation (99). In turn, these activated Jaks phosphorylate tyrosines located on 
IL-12R(32; those phosphorylated tyrosines then form docking sites for STATs (signal 
transducers and activators of transcription). The STATs bind to the phosphorylated (32 
subunit via SRC homology (SH2) domains and they themselves become phosphorylated by 
the Jaks. Phosphorylated STATs then homo or heterodimerize, translocate to the nucleus, 
bind specific DNA sequences and modulate gene expression (201). Reports indicate that 
STAT1, STAT3, STAT4 and STATS can all be activated by IL-12 (55, 78, 209). Most of IL-
12's effects, however, seem to be mediated via STAT4 homodimers, as STAT4 knock-out 
mice display impaired IFN-y production and impaired Thl polarization, the two hallmark 
activities mediated by IL-12 (88, 192) (Figure 2). 
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Figure 2. IL-12 receptor and signal transduction. The interleukin-12 (IL-12) receptor is 
composed of two chains, IL-12RJ31 and IL-12R|32, both of which have extensive homology 
to gpl30, the common receptor (3-chain of the IL-6-like cytokine superfamily. They are type 
I transmembrane glycoproteins, with molecular weights of -100 kDa (IL-12RJ31) and -130 
kDa (IL-12R(32). Co-expression of IL-12RJ31 and IL-12R|32 is required for the generation of 
high-affinity (50 pM) IL-12-binding sites, and the IL-12R|32 subunit functions as the signal-
transducing component of the high-affinity receptor complex. An 85-kDa protein that is 
associated with IL-12RJ31 is phosphorylated in response to IL-12 and might be another 
component of IL-12R. Signal transduction through IL-12R induces tyrosine 
phosphorylation, primarily of the Janus-family kinases JAK2 and TYK2, which, in turn, 
phosphorylate and activate signal transducer and activator of transcription 1 (STAT1), 
STAT3, STAT4 and STATS. The specific cellular effects of IL-12 are due mainly to its 
ability to induce activation of STAT4. Figure and legend reprinted by permission from 
Macmillian Publishers Ltd: Nature Reviews Immunology, Trinchieri, G. 3(2): 133-46, 
copyright 2003. 
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IL-12 signaling can also be negatively regulated by various mechanisms. The 
suppressor of cytokine signaling (SOCS) family of proteins hinders the actions of numerous 
cytokines; both SOCS1 and SOC3 have been shown to inhibit IL-12 signaling (45, 208). 
PIASx, a member of the PIAS (protein inhibitors of activated STATs) family also dampens 
IL-12 signaling by binding to STAT4 and preventing STAT4-dependent gene transcription 
(6). 
Functions of IL-12 
IL-12 promotes IFN-y production from T cells and NK cells via STAT4 signaling. 
Not only is IL-12 efficient at inducing IFN-y at low concentrations, but it also synergizes 
with stimulation of the TCR-CD3 complex, activation of the CD28 receptor, IL-2, IL-18 or 
IL-27 to elicit rapid and efficient IFN-y production (14, 25, 96, 124, 147). The synergistic 
effect of IL-12 and IL-2 is thought to involve both increased IFN-y mRNA stability and p38 
MAP kinase activation (24). 
IL-12 also elicits a direct proliferative response from activated T cell and NK cells, 
although an exact mechanism has not been described (146, 178). STAT4 deficient mice 
display defective IL-12-induced proliferation (88, 192). Reports indicate that IL-12 mediates 
proliferation and IFN-y production by utilizing different components of the Jak-STAT 
pathway. Using the IL-12-responsive T cell clone 2D6, Tyk2 activation was associated with 
STAT3 and STAT4 phosphorylation leading to IFN-y production, while Jak2 activation 
correlated with STATS phosphorylation and cellular proliferation (3, 180). This group 
observed somewhat similar results using activated lymph node T cells. IL-12 alone does not 
seem to induce proliferation of resting T cells, but it can enhance the proliferation of these 
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cells when stimulated with mitogens, alloantigens, anti-CD3 and phorbol esters (92, 146). 
As with IFN-y production, IL-12 synergizes with CD28 costimualtion to induce proliferation 
in resting T cells (96). 
IL-12 and Leishmania 
IL-12 is an important aspect of the protective immune response to L. major. After 
exogenous IL-12 was given to susceptible BALB/c mice at the time of infection, smaller 
lesion sizes and parasite burdens were observed, along with an enhanced Thl response and a 
decreased Th2 response (69, 183). Additionally, neutralizing IL-12 in vivo during L. major-
infection of resistant mice resulted in increased IL-4 production, decreased IFN-y production 
and non-healing lesions (67, 72, 183). Development of this Th2 response in these anti-IL-12-
treated mice was transitory, as discontinuing treatment facilitated a switch to a Thl response 
and subsequent healing (72). Studies with mice deficient in either IL-12p35, IL-12p40, IL-
12R|32 or STAT4 also failed to heal their L. major infections and developed Th2 responses 
despite having a resistant genetic background (23, 112, 176). 
Immunological tolerance 
Immunological unresponsiveness, or tolerance, may occur after Leishmania infection, 
thereby promoting chronic disease. Work by Vanloubbeeck et al demonstrated a functional 
delayed-type hypersensitivity (DTH) response upon in vivo antigen challenge in mice 
chronically infected with L. amazonensis (198). However, less IFN-y was produced by 
lymph node cells draining the site of antigen challenge upon in vitro antigen restimulation as 
compared to lymph node cells from L. amazonensis-infected mice that did not receive an 
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antigen challenge—an observation consistent with tolerance. Others have shown that 
regulatory T (Treg) cells have been shown to be necessary for the establishment of a chronic 
L. major infection with accompanying low parasite load (17). Infection of PD-L1 
(programmed death 1 ligand 1) knock-out mice with L. mexicana resulted in decreased 
parasite burden and lesion development compared to wild-type control mice (101). PD-1 and 
PD-L1 are members of the B7-l/B7-2:CD28/CTLA-4 costimulatory family of molecules. 
Studies are just beginning to elucidate PD-L1 and PD-L2 functions. Some in vitro studies 
have demonstrated that PD-LI and PD-L2 can inhibit T and B cell proliferation and cytokine 
production by promoting cell cycle arrest; others have shown that the PD-1 ligands enhance 
T cell activation (reviewed in (57)). Experiments using PD-1 knock-out mice have suggested 
a role for PD-1 in regulating tolerance because a proportion of PD-1 knock-out mice develop 
characteristics of autoimmune disorders (129, 130). Together, these studies indicate that 
immunological tolerance may contribute to the chronicity of Leishmania infection. 
Tolerance may also contribute to the establishment of other chronic infections. 
Varying degrees of dysfunctional or unresponsive CD4+ T cells are reported during persistent 
viral infections. The T cell phenotypes observed are consistent with immunological 
tolerance or nonresponsiveness. A report by Zajac et al demonstrated that chronic 
lymphocytic choriomeningitis virus (LCMV) infection of mice resulted in virus-specific 
CD8+ T cells that expressed activation markers and proliferated in vivo but were unable to 
elicit any antiviral effector functions (210). Others have observed impaired proliferation and 
effector cytokine production of antigen-specific CD4+ T cells present during chronic hepatitis 
C infection (194). Additional examples of dysfunctional T cell responses similar to these 
also exist during other chronic diseases, including host responses after infection with 
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Trypanosoma cruzi, Mycobacterium tuberculosis, human immunodeficiency virus, gamma 
herpes virus and influenza virus (5, 48, 79, 97, 205). 
Immunology textbooks define tolerance as immunological nonresponsiveness of an 
activated lymphocyte. The development of tolerance, especially self-tolerance, is an 
important dynamic process that begins with thymic selection of T cells. Only thymocytes 
that have productively rearranged the |3 chain of the T cell receptor (TCR) and whose TCRs 
exhibit self-MHC restriction are permitted to mature via a process known as positive 
selection. Cells that do not bind self-MHC are eliminated by apoptosis. Cells that survive 
positive selection then undergo negative selection, a process by which T cells are deleted if 
they possess a high affinity for self-MHC plus self-antigen. Elimination of these self-
reactive cells is important as they pose a threat of perpetuating an autoimmune response once 
mature. An estimated 99% of all thymocytes die within the thymus due to elimination during 
positive or negative selection, a phenomenon known as central tolerance (reviewed in (177)). 
Central tolerance is an efficient process, but not necessarily a complete one, as T cells 
with a low affinity for self-antigen can survive negative selection, exit the thymus and 
potentially lead to autoimmune responses (105). A second line of defense, known as 
peripheral tolerance, is therefore necessary to supplement central tolerance (84, 159). 
Peripheral tolerance is also important for preventing detrimental immune responses to 
ubiquitous proteins such as inhaled or ingested environmental antigens and gut flora 
antigens. During immune responses to invading microorganisms, various mechanisms of 
peripheral tolerance also prevent excessive inflammatory responses and subsequent host 
tissue damage. The primary mechanisms for silencing these responses involve eliminating 
responding T cells via clonal deletion or rendering these T cells unresponsive (84, 159). For 
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many years, the term anergy has been loosely used to describe unresponsive cell populations 
both in vitro and in vivo. As reviewed by Schwartz (166), T cell anergy can be generally 
defined as a tolerance mechanism in which the T cell is intrinsically functionally inactivated 
following antigen encounter, but remains alive for an extended period of time in a 
hyporesponsive state. The survival time of the cell is less than that of a normal T cell life 
span. Anergic cells are often deficient in a variety of functions, including cell division and 
cytokine production. A key characteristic of anergic cells is that they are cell-autonomous 
and not maintained by another cell type. These characteristics of anergy are generalizations; 
to be any more specific about functional defects and mechanisms one must address the 
different known types of anergic T cells individually. To avoid overuse of the term 
"anergic," unresponsive T cells observed in vitro will be described as anergic T cells whereas 
unresponsive T cells described in vivo will be referred to as adaptively tolerant throughout 
the remainder of this work. 
Clonal anergy 
Traditional clonal anergy primarily represents a category of cells experiencing growth 
arrest and usually arises when previously activated T cells are incompletely reactivated either 
by a weak stimulus or a lack of costimulation in vitro (166). Despite weak or incomplete 
activation of these T cells, the signal received is sufficient to induce new protein synthesis to 
initiate and maintain the anergic state (153). High levels of the cell-cycle inhibitor p27Kipl 
are thought to be involved in maintaining anergy as cell cycle progression seems important 
for preventing anergy; however, conflicting reports do exist (21, 149). Upon restimulation 
with antigen in the presence of APCs, clonally anergic T cells exhibit severely restricted 
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proliferation (165). IL-2 production is also limited in these cells, while production of 
effector cytokines including IL-4 and IFN-y is only slightly impaired (106, 111). Clonally 
anergic cells do not seem to require antigen to maintain their unresponsive state, as 
unresponsiveness in vitro can remain for weeks after the removal of antigen and APCs (166). 
Proliferation and IL-2 production by clonally anergic cells can typically be restored upon 
exposure to a phorbol ester such as phorbol 12-myristate-13-acetate (PMA) and ionomycin 
(47, 100). Addition of IL-2 to clonally anergic cells can also reverse anergy (19), as does 
stimulation with anti-OX40 antibody (12). Clonally anergic cells have only been described 
in vitro. A slightly different pattern of anergy was observed in vivo and subsequently 
described as adaptive tolerance. 
Adaptive Tolerance 
Adaptively tolerant T cells are mature cells that have adapted to persistent antigen 
stimulation by down-modulating (or tuning) their sensitivity to specific antigen restimulation 
(166). This behavior is thought to be important for maintaining tolerance to self-antigen in 
the periphery. Adaptive tolerance, also known as in vivo tolerance (145), was first observed 
in a population of T cells that remained following expansion and cell death induced by 
superantigen stimulation in vivo (89, 154, 157). Antigen-specific models were developed 
later in which T cells from a TCR transgenic mouse were adoptively transferred into either 
an antigen-bearing or an antigen-free recipient that received a subsequent antigen challenge 
(142, 158, 159). These and other studies have yielded much insight into the characteristics of 
adaptively tolerant T cells, which differ considerably from those of clonally anergic T cells. 
The presence of persistent antigen is necessary for maintenance of this tolerant phenotype 
(142, 158, 189). Adaptive tolerance is initiated in naïve T cells, and these T cells proliferate 
and produce IL-2 in response to antigen stimulation. Adaptively tolerant T cells differentiate 
to various degrees and then down-regulate proliferation and production of effector cytokines, 
including IFN-y and IL-4, in the presence of persistent antigen (171, 189). Once antigen is 
removed, these T cells regain the ability to proliferate and produce cytokines. 
Regulation o/T cell signaling in adaptive tolerance 
The hyporesponsiveness of adaptively tolerant T cells involves T cell receptor (TCR) 
desensitization rather than decreased expression of the TCR (189). Analyses of TCR 
signaling pathways in adaptively tolerant T cells have revealed a deficit in Zap70 kinase 
activity (27, 118). In turn, this defect results in decreased levels of phosphorylated LAT 
(linker of activated T cells) and phosphorylated phospholipase Cyl (PLCyl). Together, these 
defects greatly impair the release of intracellular calcium, a characteristic shared by many 
examples of adaptively tolerant T cells (27, 190, 196). Adaptively tolerant T cells also fail to 
degrade IkB, which prevents signaling via the NF-kB pathway. In contrast, ERK1/2 
phosphorylation is only slightly impaired in adaptively tolerant T cells, as is activation of the 
Ras/MAP kinase pathway (27). 
Adaptively tolerant T cells also possess defects in IL-2 receptor signaling, as providing 
exogenous IL-2 does not reverse the tolerant phenotype of these cells as it does for clonally 
anergic T cells (166). Expression of the IL-2 receptor alpha chain (CD25) is highly variable 
among various models of adaptive tolerance. In some experiments, low doses of antigen are 
sufficient for CD25 expression, while high doses are necessary in others. Another study 
indicates that adaptively tolerant T cells do not re-express CD25 upon in vitro stimulation 
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(189, 190, 196). The exact mechanisms involved in aberrant IL-2 signaling are currently 
unknown for adaptively tolerant T cells. 
CTLA-4 is a well-known regulator of T cells; however, the exact role of CTLA-4 in 
adaptive tolerance is controversial, as both affirmative (56, 145) and negative reports (50, 
174) have been published. Work by Inobe and Schwartz indicates that involvement of 
CTLA-4 in adaptive tolerance is complex, as CTLA-4 slows CD4+ T cell responses such as 
proliferation and cytokine production but is not necessary for tuning mechanisms involved in 
adaptive tolerance (77). Additional work indicates that CTLA-4 could be mediating, in part, 
the defects in IL-2 signaling observed in adaptively tolerant T cells (202). 
Antigen load and the induction of adaptive tolerance 
Various models proposed by Grossman, Paul and colleagues predict how the strength 
and quality of an antigenic stimulation as well as the amount of antigen present during 
stimulation influence the behavior of a T cell. At any given time in a population of T cells, 
various states of maturation exist. These T cells possess different capacities for either self-
renewal or differentiation; two competing cellular events that are regulated by recurrent 
interactions with antigen, APCs and other T cells (59, 60, 62). T cell differentiation is often 
considered in a linear fashion, beginning with the naïve state, ending with death and 
consisting of various stages of differentiation in between. Grossman and colleagues propose 
that T cells transition between a resting and activated state at each stage of differentiation 
based on interactions with antigen and APCs (Figure 3). If antigen and activated APCs are 
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present, T cells become activated and subsequently undergo either self-renewal or 
differentiation. Activated T cells also secrete and respond to cytokines, which further 
influence the balance between self-renewal and differentiation (60). In the absence of 
polarizing cytokines, brief antigenic stimulation in vitro or in vivo results in proliferation of 
non-polarized T cells. However, prolonged stimulation in the presence of IL-12 or IL-4 
creates populations of polarized Thl or Th2 cells, respectively (75). In vivo stimulation with 
low doses of antigen induced undifferentiated, proliferating CD4+ T cells that produced IL-2 
but not IFN-y or IL-4. Upon culture in the presence of the appropriate polarizing cytokines, 
these cells, known as T helper primed precursor cells, were able to differentiate into fully 
committed Thl or Th2 cells (200). 
Under conditions of recurrent or continual antigen stimulation, effector cells may 
limit their own numbers by changing the balance between self-renewal and differentiation. 
The tunable activation threshold (TAT) model proposed by Grossman and Paul states that T 
cell activation is a threshold phenomenon and that the threshold is tuned by the stimulatory 
experience of the cell (61, 62). T cells are predicted to respond to perturbations in their 
environment, such as to a change in the level of stimulation. Moreover, T cells are predicted 
to adapt to continuous or recurrent stimulation by updating their threshold for activation, 
thereby preventing resting T cells from becoming activated effector cells in response to 
ambient interactions. Instead, resting lymphocytes only fully respond when a sufficiently 
rapid increase occurs in their level of stimulation upon infection with a pathogen. For 
example, autoreactive T cells in the periphery could become activated when presented with 
self-antigen. However, because self-antigen is continually being processed and presented, 
these cells have increased their threshold for activation to a level beyond what they normally 
encounter, thus maintaining peripheral tolerance. In contrast, invading pathogens provide not 
only a source of antigen for presentation, but also provide a source of inflammatory 
mediators that produce a significant perturbation in a T cell's environment. This rapid 
increase in the amount of antigen presented promotes the development of a productive 
immune response. 
When lymphocytes are subjected to recurrent stimulation, they either respond by 
differentiating or by adapting and becoming less responsive. As predicted by the TAT 
model, adaptively tolerant T cells have been shown to tune their activation threshold 
according to the amount of antigen present in their environment (171, 189). Work by 
Tanchot et al demonstrated that retransfer of adaptively tolerant T cells into a second antigen-
bearing host results in a reduced in vivo proliferative response. Moreover, these cells slowly 
entered into what was described as a deeper state of unresponsiveness, evidenced not only by 
a decrease in cytokine production upon in vitro stimulation, but also by a weak in vivo 
proliferative response upon transfer into yet a third antigen-bearing host (189). Chronic 
infections such as tuberculosis or HIV or slow-progressing forms of cancer may provide yet 
another scenario for T cell activation under the TAT model. The gradual accumulation of 
antigen may elicit a weak response from T cells as they continually update their antigen 
threshold based on cues from their environment. Some characteristics of activation tuning by 
adaptively tolerant T cells is observed during persistent viral infection with LCMV, hepatitis 
C, human immunodeficiency virus, gamma herpes virus and influenza virus (5, 48, 79, 139, 
194, 210) and other chronic diseases, including those caused by infection with Trypanosoma 
cruzi and Mycobacterium tuberculosis (97, 205). Interestingly, a recent report by Barber et 
al is the first of its kind to identify a specific mechanism of CD8+ T cell dysfunction during 
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chronic LCMV infection. PD-1 (programmed death-1) expression was found to be 
selectively enhanced on adaptively tolerant T cells; in vivo administration of antibodies that 
blocked the interaction of this inhibitory receptor with its ligand, PD-1L, enhanced T cells 
responses (13). Identification of this mechanism may represent a potential strategy for 
treating chronic viral infections. 
In addition to interactions with antigen, APCs and other T cells, cytokines can also 
influence the T cell decision between self-renewal and differentiation. Just as the presence of 
polarizing cytokines including IL-12 and IL-4 at the time of antigenic stimulation can 
influence a cell's decision to differentiate to a Thl or Th2 phenotype, respectively, the 
presence of regulatory cytokines can influence differentiation towards a suppressive or 
regulatory phenotype (60) (Figure 3). These cytokines, including IL-10 and TGF-|3, can 
either act upon APCs, which in turn direct the activities of T cells, or they can act directly on 
T cells themselves (26, 132). Should the former scenario be the case, an expansion of Treg 
cells may be observed. These Treg cells, in turn, suppress the proliferation and subsequent 
differentiation of other CD4+ T cells (120, 148, 199). Alternatively, an increase in the 
concentration of regulatory cytokines may act directly on conventional antigen-specific T 
cells themselves, thereby conferring suppressive activity to those cells. This phenomenon 
could have a spreading (or "infectious") character, as these cells may recruit other T cells 
stimulated at the same time to acquire a suppressor/regulatory function (60). 
Regulatory T cells are an important mechanism of immune regulation. 
Unfortunately, the exact definition of what constitutes a Treg cell, where and how they 
develop and the antigenic specificity and mechanisms of actions are not readily defined. 
Bluestone and Abbas contend that Tregs cells can be classified into two general categories, 
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natural and adaptive (or inducible) Tregs (20). Natural Tregs are CD25+ CD4+ T cells that 
develop in the thymus and function primarily to maintain self-tolerance. In contrast, the 
category of adaptive Tregs is a broad one and encompasses Treg cells that function to maintain 
homeostatic control over various adaptive immune responses that may or may not be 
involved in maintaining self-tolerance. Mechanisms of adaptive Treg suppression vary, and 
can include cell-cell contact, APC contact and cytokine-mediated suppression. Adaptive Treg 
cells may be derived from either natural Tregs or from classical T cell subsets. Although these 
cells are thought to arise after antigen stimulation, such as after organ transplantation or 
infection, whether or not these Tregs are antigen specific is unclear (20). Many have 
speculated that IL-2 promotes Treg development, as Tregs are absent in IL-2-defïcient mice 
(51, 110). However, a recent report indicates that IL-2 is dispensable for Treg development 
but necessary for Treg maintenance (49). 
A report by Duthoit et al demonstrates perhaps yet another type of adaptive 
regulatory cell—stimulation refractory CD4+ T cells (42). Wilde and Fitch first described 
that CD4+ T cells maintained in continuous culture with IL-2 became profoundly 
unresponsive to antigenic restimulation for a period after initial antigenic stimulation (203, 
204). This refractory period was found to increase in length with increasing doses of IL-2 
and was associated with enhanced activation-induced cell death (AICD) upon TCR re-
engagement (191). Stimulation refractory CD4+ T cells are an activated T cell population 
that, like anergic cells and Tregs, can suppress the antigen-specific proliferative responses of 
naïve T cells (42). Naïve T cells that failed to proliferate in the presence of stimulation 
refractory CD4+ T cells did engage antigen and were partially stimulated as evidenced by 
enhanced CD69 expression; nevertheless, these naïve T cells failed to enter the cell cycle, 
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were blocked at the G0/G1 phase and failed to produce IL-2. Suppressed naïve T cell 
proliferation was observed even in the presence of high levels of IL-2, indicating that failure 
of naïve T cells to produce IL-2 in response to antigen was not the sole reason for the 
proliferation defect. Naïve T cells also appeared to be able to bind IL-2, as the high affinity 
IL-2 receptor was expressed on all T cells exhibiting suppressed proliferation (42). Norris et 
al observed a suppressive role for IL-2 dependent upon T cell activation status (131). In 
rested T cell cultures, IL-2 promoted antigen-specific proliferation and IL-2 production. For 
activated T cells, IL-2 inhibited antigenic reactivity by prolonging post-activational 
refractoriness and limiting subsequent IL-2 responsiveness and proliferation, although not via 
down-regulation of the high affinity IL-2 receptor (131). Stimulation refractoriness may 
function to limit not only the response of antigen specific T cells themselves, but also to limit 
bystander T cell activation. During an immune response, stimulation refractoriness may help 
prevent T cell adaptive tolerance and promote memory cell development as antigen load 
decreases (87). However, during chronic infections, it is possible that the continual antigenic 
stimulation of T cells may perpetuate a population of stimulation refractory T cells that 
suppress naïve T cell proliferation and differentiation, thereby failing to mount a productive 
CD4+ T cell response that decreases antigen load and resolves infection. 
Role of dendritic cells in promoting tolerance 
T cells can be rendered immunologically tolerant when primed by immature dendritic 
cells (65). During "steady-state" conditions (normal physiological conditions in which there 
is no infection or inflammation), dendritic cells reside in peripheral tissues as immature 
APCs; these DCs express low levels of MHC II, few costimulatory molecules and do not 
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secrete cytokines. However, these immature DCs are particularly adept at capturing antigens 
in their environment. When antigen is targeted to steady-state DCs, they upregulate MHC II 
and induce extensive T cell proliferation. However, those T cells do not polarize nor do they 
experience prolonged expansion or activation. These results indicate that in the absence of 
inflammation, steady-state DCs function primarily in maintaining peripheral tolerance (65). 
Under certain conditions, steady-state DCs can become migratory, which is a 
characteristic of mature DCs. The details of this change are currently unknown but may 
involve tumor necrosis factor alpha (TNF-a) or IL-10. These DCs appear to enhance 
expression of MHC and costimulatory molecules and process and present antigen; however, 
no inflammatory signals are present during steady-state conditions to promote production of 
proinflammatory cytokines such as IL-12, thereby giving them a semi-mature phenotype. In 
turn, these semi-mature DCs become tolerogenic by inducing Treg cells (107). Similar to 
semi-mature DCs, pathogen-driven immature regulatory DCs do not support substantial 
effector T cell development, and instead induce IL-10+ Treg cells. However, they are 
different from semi-mature DCs in that they are unresponsive to inducers of DC maturation 
such as lipopolysaccharide (LPS) or CD40 stimulation (172). These pathogen-induced 
immature DCs have been shown to develop in response to infection with Plasmodium 
falciparum and hepatitis C virus (134, 8). In contrast to pathogen-driven immature 
regulatory DCs, pathogen-mature regulatory DCs typically express high levels of MHC and 
costimulatory molecules, although CD40 expression is slightly reduced compared to mature 
immunogenic DCs. These DCs are potent at T cell stimulation, but they produce low levels 
of cytokines, including IL-12 family members, type I interferons, TNF-a, IL-6 and IL-10 
(172). Pathogenic compounds that prime for pathogen-mature regulatory DCs include 
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lysophosphotidylserine from Schistosoma mansoni and filamentous haemagglutinin from 
Bordetella pertussis (114, 197). Together, these reports demonstrate a wide variety of DC 
phenotype s and functions in promoting various aspects of T cell tolerance. 
Overview of thesis and project objectives 
Infection of C3H mice provides an excellent experimental model for studying the host 
immune response associated with cutaneous leishmaniasis. C3H mice challenged with L. 
major develop a polarized Thl response and subsequently heal. In contrast, infection of C3H 
mice with L. amazonensis results in chronic cutaneous lesions containing up to 108 parasites 
and low to undetectable amounts of both IFN-y and IL-4 after in vitro recall stimulation of 
draining lymph node cells. The objective of this dissertation was to characterize the 
dysfunctional adaptive T cell immune response associated with L. amazonensis infection. 
Specifically, the aims were to (1) determine if polarized, antigen-responsive or tolerogenic 
CD4+ T cells develop during L. amazonensis infection, (2) assess both the in vitro and in vivo 
IL-12 responsiveness of CD4+ T cells present during L. amazonensis infection and (3) 
understand the regulation of IL-12 responsiveness during L. amazonensis infection. 
Information generated from this dissertation has provided insight into why a productive 
adaptive immune response fails to develop during L. amazonensis infection. By 
understanding this dysfunctional immune response, the potential exists to develop new 
therapeutic strategies that will diminish parasite load and perpetuate a productive CD4+ Thl 
cell response. Perhaps, too, this information will not only aid in the fight against 
leishmaniasis but also against the many other chronic diseases caused by intracellular 
pathogens that burden our world. 
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Chapter 2 
Antigen-responsive CD4+ T cells from C3H mice chronically infected 
with Leishmania amazonensis are impaired in their transition to 
an effector phenotype 
Amanda E. Ramer, Yannick F. Vanloubbeeck and Douglas E. Jones 
A paper published in Infection and Immunity 
Abstract 
C3HeB/FeJ mice challenged with Leishmania major develop a polarized Thl 
response and subsequently heal, whereas L. amazonensis challenge leads to chronic lesions 
with high parasite loads at ten weeks post-infection. In this study, a comparison of draining 
lymph node cells from L. amazonensis- and L. major-infected mice at ten weeks post­
infection showed an equivalent percentage of effector/memory phenotype CD44hl CD4+ T 
cells producing IL-2 and proliferating after antigen stimulation. However, these cells 
isolated from L. amazonensis-'mfected mice were not skewed towards either a Thl or Th2 
phenotype in vivo as evidenced by their unbiased Thl/Th2 transcription factor mRNA 
profile. In vivo antigen stimulation with added IL-12 failed to enhance IFN-y production of 
CD4+ T cells from L. amazonensis-infected mice. Antigen stimulation of CD4+ T cells from 
L. amazonensis-infected mice in vitro in the presence of IL-12 resulted in production of only 
10-15% of the IFN-y produced by T cells from L. major-infected mice under identical 
* Reprinted from volume 74, pages 1547-1554, © 2006, with permission from the American 
Society for Microbiology. 
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conditions. These results suggest that the CD4+ T cell response during chronic L. 
amazonensis infection is limited during the transition from an early-activated CD4+ T cell 
population to an effector cell population, and demonstrate that these T cells have an intrinsic 
defect beyond the presence or absence of IL-12 during antigen stimulation. 
Introduction 
Experimental infection of C3H and C57BL/6 mice with the obligate intracellular 
protozoan parasite Leishmania major results in a CD4+ T cell population that produces IFN-
Y, perpetuates a Thl response and ultimately promotes resistance and a productive memory 
response (reviewed in (19-21); (28)). In contrast, infection of the C3HeB/FeJ, C57BL/6 or 
C57BL/10 strains of mice with L. amazonensis results in chronic cutaneous lesions 
containing up to 108 parasites and low to undetectable levels of both IFN-Y and IL-4 in the in 
vitro recall responses of draining lymph node (DLN) cells (1, 13, 15). CD4+ T cells from L. 
amazonensis-infected mice express low levels of IL-12R|32—a phenomenon that was found 
to be IL-4-independent (15). Additionally, the poor Thl response associated with L. 
amazonensis infection has been shown to persist even in the absence of either IL-4 or IL-10 
and also in the presence of exogenous IL-12 (14, 15, 26). The failure of L. amazonensis-
infected mice to develop an effective Thl response and heal their infections has prompted us 
to determine whether this CD4+ T cell defect is the result of an absence of antigen (Ag)-
responsive effector/memory CD4+ T cells or an inability of Ag-responsive cells to progress 
to a productive a Thl response. 
We present evidence that the effector/memory phenotype (CD44hl) CD4+ T cells 
present during L. amazonensis infection exist in vivo as an unskewed T cell population as 
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evidenced by an unbiased T-bet and GATA-3 mRNA expression profile and are only 
partially responsive to IL-12 both in vitro and in vivo. However, these cells are not anergic 
as evidenced by their Ag-responsiveness and ability to proliferate and produce IL-2 to the 
same extent as CD44hl CD4+ T cells from L. major-infected mice. L. major-infected mice 
were included in our analyses as a control for a functional Thl effector/memory response. 
Moreover, CD44hl CD4+ T cells exist in equivalent percentages in both L. amazonensis- and 
L. major-infected C3H mice. Our results indicate that the large parasite load and non-healing 
phenotype of L. amazonensis-'mfected mice occurs in the presence of an Ag-responsive CD4+ 
T cell population limited by an inability to progress from an early-activated phenotype to an 
efficient effector CD4+ T cell population. Furthermore, the data suggest that the failure of 
this cell population to become efficient Thl effector cells is not due to the absence of IL-12 
or the inability of the cells to respond to IL-12. 
Materials and Methods 
Parasites and Antigens. Culture of L. amazonensis (MHOM/BR/OO/LTBOO16) and L. major 
(MHOM/IL/80/Friedlin) and preparation of parasite antigens were performed as previously 
described (14). In all experiments involving Ag stimulation, cells were stimulated with the 
matching freeze-thawed promastigote Ag. The parasite burden of infected footpads was 
determined using a limiting dilution assay as described (1) and expressed as the negative log 
of parasite titer. 
Mice. Female C3HeB/FeJ mice (six to eight weeks of age) were either bred in-house or 
obtained from The Jackson Laboratory (Bar Harbor, ME) and maintained in a specific 
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pathogen-free facility. The Committee on Animal Care at Iowa State University approved all 
protocols involving animals. Mice were injected with 5 x 106 stationary phase promastigotes 
in 50 \i\ PBS in the left hind footpad. Lesion size was monitored with a dial micrometer and 
expressed as the difference in footpad thickness between the infected and uninfected feet. 
Between three and twelve mice were pooled per group for each experiment and were 
sacrificed at ten weeks post-infection. For the in vivo Ag challenge, L. amazonensis-infected 
mice at ten weeks post-infection were injected in the right hind footpad with 20 [xg of L. 
amazonensis Ag + 0.2 [ig of IL-12 (Peprotech, Rocky Hill, NJ) in a total volume of 50 [il of 
PBS or with 50 ^1 of PBS alone. L. mayor-infected mice at ten weeks post-infection were 
injected in the right hind footpad with 20 ^ig of L. major Ag. Mice were sacrificed at 48 
hours post-Ag challenge. 
Flow Cytometry and Proliferation Assay. Memory phenotype of T cells in the draining 
lymph node (DLN) was assessed ex vivo using flow cytometry as described in (15). Cells 
were surface stained with FITC-labeled anti-CD4 (H129.19), PE-labeled anti-CD62L (MEL-
14), Cychrome-labeled CD44 (IM7) or the appropriate isotype control. All antibodies were 
obtained from Pharmingen (San Diego, CA) unless stated otherwise. Cells were acquired on 
a FACScan flow cytometer (Becton Dickinson, San Jose, CA) and data were analyzed using 
CellQuest software (Becton Dickinson). 
To evaluate intracellular cytokines, 1 x 106 DLN cells were plated per well in a 96-
well U-bottom plate with 50 [ig/ml of Ag in complete tissue culture medium (CTCM; 
DMEM containing 4.5 mg of glucose/ml, 2 mM L-glutamine, 100 U penicillin, 100 ^ig 
streptomycin/ml, 25 mM HEPES, 0.05 piM 2-mercaptoethanol and 10% fetal bovine serum). 
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After 18 h, cells were stimulated with PMA (50 ng/ml) and ionomycin (50 ng/ml) in the 
presence of brefeldin A (10 |xg/ml) for 6 h. Cells were harvested, washed, stained with either 
FITC-or PE-labeled anti-CD4, Cychrome-labeled anti-CD44 or the appropriate isotype 
controls and fixed. Intracellular cytokines were assayed as described in (15). Antibodies 
used included FITC-labeled IL-2 (JES6-5H4), PE-labeled IFN-y (XMG1.2), PE-labeled IL-4 
(11B11) or an appropriate isotype control. Cells were acquired as described above. 
Cell division was assessed by flow cytometry using the dye carboxyfluorescein 
diacetate succinimidyl ester (CFSE) (Molecular Probes, Eugene, OR) as previously described 
(15). One million cells were cultured per well of a 96-well U-bottom plate with or without 
50 [xg/ml Ag in CTCM. After 4 days, the cells were harvested, washed, stained with PE-
labeled anti-CD4 and Cychrome-labeled anti-CD44 or the appropriate isotype controls, fixed 
and acquired as described above. 
CD4+ T Cell Purification. CD4+ T cells were purified from lymph nodes via either magnetic 
positive selection using anti-CD4 MicroBeads or magnetic depletion using a biotin-
conjugated antibody cocktail and anti-biotin MicroBeads (Miltenyi Biotec, Auburn, CA) 
according to the manufacturer's protocol. Cells were subjected to one to three passes 
through an AutoMACS cell sorter. The purity of the CD4+ T cells was routinely 90% or 
greater. CD44hl CD4+ T cells from the DLN were stained with FITC-labeled anti-CD4 and 
Cychrome-labeled anti-CD44 and sorted with an Epics Altra Cell Sorter (Beckman Coulter, 
Fullerton, CA). The purity was of the CD44hl CD4+ T cells routinely 90% or greater. 
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Polarization Assay, Recall Responses and ELISAs. For polarization assays, spleen cells from 
naïve female C3HeB/FeJ mice were incubated with a lysing buffer (0.15 M ammonium 
chloride, 10 mM potassium bicarbonate and 0.1 mM ethylenediaminetetra-acetic acid) to lyse 
red blood cells. Splenocytes were treated with mitomycin C (Sigma) at a final concentration 
of 50 fig/ml at 37°C for 20 min and washed five times with an excess of complete media. In 
a 96-well U-bottom plate, each well contained 1 x 105 purified CD4+ T cells, 1 x 106 
mitomycin C-treated splenocytes and 50 |ig/ml of Ag in CTCM. All co-cultures were 
expanded for five days with either 2 ng/ml of IL-12 (Peprotech) and 10 fxg/ml of anti-IL-4 
(Pharmingen, Thl conditions) or with no additional cytokines and antibodies (neutral 
conditions). Supernatants were harvested and assayed via ELIS A for IFN-y; sensitivity 
ranged between 39 and 156 pg/ml. All ELISA antibodies were purchased from Pharmingen 
and used according to manufacturer recommendations. Ag-pulsed mitomycin C-treated 
splenocytes alone were cultured under polarizing conditions to determine baseline amount of 
cytokine production. 
For recall responses, 1 x 106 LN cells draining the site of Ag challenge of infected 
mice were cultured in each well of a 96-well plate with or without 50 [xg/ml of Ag in CTCM. 
After 3-d, supernatants were assayed for IFN-y via ELISA as described above. 
Real-time RT-PCR. Real-time RT-PCR was performed on either CD44hl CD4+ or CD4+ T 
cells as described in (26). 
Statistical Procedure. Statistical analysis was performed using Statview (SAS, Cary, NC). 
When treatment groups were compared, the data were analyzed with the Fisher's Protected 
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Least Significant Difference (PLSD) post-hoc test. When two treatments within a group 
were compared, data were analyzed using a paired t-test. Differences were considered 
significant when p < 0.05. 
Results 
Both L. amazonensis- and L. mayor-infected mice have equivalent percentages of CD4+ T 
cells with an effector/memory phenotype. 
C3H mice infected with L. major develop transient lesions that subsequently heal 
with less than 100 parasites detectable by ten weeks post-infection. However, L. 
amazonensis infection of C3H mice results in chronic lesions with up to 108 parasites 
detectable in the footpad at ten weeks post-infection (Figures 1A and B). Moreover, mice 
infected with L. amazonensis fail to mount an effective Thl response and consistently 
demonstrate poor effector cytokine production in recall responses of the draining lymph node 
(DLN). Because of these findings, we hypothesized that these mice might have a reduced 
percentage of effector/memory phenotype CD4+ T cells in the DLN when compared to L. 
mayor-infected mice. However, an ex vivo analysis of the DLN of mice at ten weeks post­
infection revealed that both L. amazonensis- and L. major-infected mice had equivalent 
percentages of CD4+ T cells that were CD44hl and CD62L10 (Figure 1C). Absolute numbers 
of cells per DLN averaged 59.6 x 106 for L. amazonensis-infected mice and 28.1 x 106 for L. 
major-infected mice, indicating that L. amazonensis-infected mice have, overall, more 
effector/memory phenotype CD4+ T cells at ten weeks p.i. than do L. mayor-infected mice. 
Moreover, both groups of Leishmania-infected mice had significantly greater percentages of 
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Figure 1. Both L. amazonensis- and L. major-infected mice have equivalent percentages of 
CD44hl CD62L10 CD4+ T cells in the DLN. (A) Lesion development in C3H mice infected 
with either L. amazonensis or L. major. Data are represented as the mean + the standard 
deviation of the mean of one representative experiment with eight mice per group. (B) 
Parasite burden in the feet of L. amazonensis- or L. major-infected mice at ten weeks post­
infection. Data are represented as the mean + the SEM of three separate experiments. * 
represents a statistically significant difference at p < 0.05 as determined by Fisher's PLSD 
test. (C) DLN cells were harvested from mice infected with either L. amazonensis or L. 
major for ten weeks or from age-matched uninfected controls and stained for flow cytometry 
as described in materials and methods. The dot plots are based on a live CD4+ gate and are 
representative of four separate experiments. 
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these T cells than uninfected mice, indicating that this increase was associated with infection. 
These data indicate that the susceptibility of C3HeB/FeJ mice to L. amazonensis is not due to 
an absence of effector/memory phenotype CD4+ T cells in the DLN, and that the percentage 
of effector/memory phenotype CD4+ T cells present in the DLN of L. amazonensis-infected 
mice is not limited in comparison to L. major-infected mice. 
CD44hl CD4 T cells from L. amazonensis-infected mice respond to parasite Ag by 
producing IL-2 and proliferating but do not have a skewed Thl/Th2 response. 
The CD4+ T cell response associated with L. amazonensis-infection has been 
previously characterized as defective in terms of proliferative responses, Ag-specific 
cytokine production and chemokine and IL-12RJ32 mRNA expression (13, 15). Our 
observations of an effector/memory phenotype CD4+ T cell population that increases in the 
DLN of mice chronically infected with L. amazonensis prompted us to specifically assess the 
functional capabilities of the CD44hl CD4+ T cell population. After a 24-hour Ag stimulation 
of DLN cells, no significant difference was seen between the cells isolated from either L. 
amazonensis- or L. mayor-infected mice in terms of the percentage of CD44hl CD4+ T cells 
that produced IL-2 as assessed by intracellular staining (Figure 2A). In addition, the ability 
of CD44hl CD4+ T cells to proliferate after four days of Ag stimulation was evaluated using 
CFSE labeling. We found that 73% of these cells from both L. amazonensis-infected mice 
and L. major-infected mice proliferated (Figure 2B). CD4+ T cell proliferation in the 
presence of Ag was almost exclusively from CD44hl CD4+ T cells (Figure 2C). CD4+ T cell 
IL-2 production in the presence of Ag was predominantly from this cell population as well 
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Figure 2. The Ag-specific CD44hl CD4+ T cell population from mice chronically infected 
with L. amazonensis is capable of producing IL-2 and proliferating. (A) DLN cells were 
harvested from infected mice at ten wks p.i., stimulated for 24 h with 50 ug/ml of Ag, stained 
with fluorescent antibodies against CD4, CD44 and IL-2 and then analyzed by flow 
cytometry (see materials and methods). Cells from L. amazonensis-infected mice were 
stimulated with L. amazonensis Ag and cells from L. major-infected mice were stimulated 
with L. major Ag. Data are represented as the mean + the SEM of three separate 
experiments. (B) DLN cells were harvested at ten weeks p.i., labeled with CFSE, cultured 
with (Ag Stim) or without (No Stim) 50 pig/ml of their respective Ag for four days, stained 
with fluorescent antibodies against CD4 and CD44 and then analyzed by flow cytometry. 
Cells from uninfected mice were stimulated with L. amazonensis Ag; cells from infected 
mice were stimulated as described in A. Data are represented as the mean + the SEM of five 
separate experiments and is expressed as the percentage of CD44hl CD4+ T cells that are 
proliferating. * represents a statistically significant difference between No Stim and Ag Stim 
within a group at p < 0.05 as determined by a paired t test. (C) Cells were cultured and 
assayed as described in B. All dot plots are for cells simulated with 50 [j,g/ml Ag and are 
based on a live CD4+ gate and are representative of five separate experiments. Quadrant 
statistics are percentages and are calculated based on a live CD4+ gate. 
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(data not shown). Thus, CD44hl expression defines Ag-reactive cells with similar 
proliferative and IL-2-producing capabilities in both L. amazonensis- and L. major-infected 
mice. Although central memory and effector memory CD4+ T cells have recently been 
defined by CD62Lhl and CD62L10 expression, respectively, during L. major infection (28), 
these populations do not significantly differ between L. amazonensis- and L. major- infected 
mice. These results demonstrate that the CD4+ T cell population responds to L. amazonensis 
infection in vivo by enhancing the percentage of cells that recognize parasite antigen and that 
these cells undergo at least the early events of T cell activation including upregulation of 
CD44 and proliferation. Based on these results, we were interested in determining whether 
there would be differences in T cell characteristics associated with a mature Ag-responsive 
cell population. 
Numerous studies have characterized the transcription factors T-bet and GATA-3 as 
master regulators of the Thl and Th2 lineage fates, respectively, and the commitment of a T 
cell population towards either phenotype is associated with an upregulation of one of these 
transcription factors during progression through the activation pathway (25, 29). To that end, 
we assayed CD44hl CD4+ T cells isolated ex vivo from the DLN of infected mice for T-bet 
and GATA-3 mRNA expression via real-time RT-PCR. Consistent with a Thl effector 
phenotype, CD44hl CD4+ T cells from L. major-infected animals had a significant increase in 
T-bet expression compared to cells from uninfected animals. CD44hl CD4+ T cells from L. 
amazonensis-infected mice, however, expressed 51% less T-bet mRNA when compared to 
CD44hl CD4+ T cells from L. major-infected mice (Figure 3 A) and there was no significant 
difference in T-bet mRNA expression between CD44hl CD4+ T cells from L. amazonensis-
infected and uninfected mice. In contrast, GATA-3 mRNA expression was found to be 
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similar between the CD44hl CD4+ T cells from both L. amazonensis- and L. major-infected 
mice, and this expression level was significantly lower than that of CD44hl CD4+ T cells from 
uninfected mice (Figure 3B). Together, these results indicate an unbiased T helper 
phenotype of the CD44hl CD4+ T cells in vivo during L. amazonensis infection as indicated 
by the absence of enhanced T-bet or GATA-3 mRNA expression over uninfected levels. 
Effector cytokine production by the Ag-responsive CD44hl CD4+ T cells was assessed 
after stimulating the DLN cells with Ag for 24 hours and determining IFN-Y- or IL-4-positive 
cells via intracellular staining. The percentage of CD44hl CD4+ T cells producing IFN-y from 
L. amazonensis mice was found to be 53% less than cells from L. major-infected mice 
(Figure 3C). In addition, there was no significant difference in the percentage of Re­
producing CD44hl CD4+ T cells from L. amazonensis-infccied mice compared to cells from 
L. major-infected mice. As with IL-2 production and proliferation, effector cytokine 
production in the presence of Ag was almost exclusively from the CD44hl CD4+ T cell 
population, thus reinforcing that these cells constitute the Ag-specific CD4+ T cell population 
(data not shown). The ratio of IFN-7-producing cells to IL-4-producing cells was greater 
than 10 to 1 for the CD44hl CD4+ population derived from L. ma/or-infected mice. Although 
L. amazonensis-'mÏQCteà mice had more IFN-y-producing than IL-4-producing CD44hl CD4+ 
T cells (3 to 1), the ratio was not as skewed towards a Thl response as that of cells from L. 
major-infected mice. This 3 to 1 ratio reflects the absence of a productive Thl immune 
response in L. amazonensis-infected mice rather than an enhanced Th2 phenotype. 
Collectively, these intracellular staining results closely reflect the Thl/Th2 transcription 
factor mRNA expression profile and indicate that the Ag-responsive CD4+ T cells associated 
with chronic L. amazonensis infection exist in vivo as an unskewed population. 
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Figure 3. CD44hl CD4+ T cells from L. amazone nsLs-mïcctcd mice do not have a skewed 
Thl/Th2 response. At ten weeks p.i., CD44hl CD4+ T cells from the DLN of Leishmania-
infected or control mice were sorted and analyzed ex vivo for (A) T-bet and (B) GATA-3 
mRNA expression via real-time RT-PCR. Data are represented as the mean + the S EM of 
four separate experiments. (C) DLN cells were harvested at ten weeks p.i., stimulated for 24 
h with 50 [xg/ml of their respective Ag as described in Figure 2A, stained with fluorescent 
antibodies against CD4, CD44 and either IFN-y or IL-4 and then analyzed by flow 
cytometry. Data are represented as the mean + the SEM of six separate experiments. * 
represents a statistically significant difference between indicated groups at p < 0.05 as 
determined by Fisher's PLSD test. 
Despite in vivo Ag-responsiveness, CD4+ T cells present in L. amazonensis-infected mice 
exhibit limited IL-12 responsiveness. 
Considering that IL-12 expression is necessary for the development and maintenance of 
a CD4+ Thl phenotype in vivo during L. major-infection (reviewed in (20)), and that IL-12 
production has been shown to be limited during L. amazonensis infection (13, 15, 26), we 
determined if the CD4+ T cell population of mice chronically infected with L. amazonensis 
could respond to IL-12 in vivo in the presence of Ag. Since a delayed-type hypersensitivity 
reaction has long been utilized as a technique to evaluate memory CD4+ Thl cell responses 
in vivo (reviewed in (18)), we infected mice in the left hind footpad with L. amazonensis for 
ten weeks and then injected the right hind footpad with either L. amazonensis Ag, Ag plus 
IL-12 or PBS. At 48 hours post-Ag challenge, there was a significant increase in the percent 
of CD44hl CD4+ T cells present in the lymph node (LN) draining the site of Ag challenge 
over the PBS-injected controls in L. amazonensis-infected mice (Figure 4A), again 
demonstrating that CD44hl CD4+ T cells do respond to Ag in vivo. However, the recall 
responses of the LN cells draining the site of Ag challenge showed no significant 
enhancement in IFN-y production regardless of the presence or absence of IL-12 at the time 
of Ag challenge (Figure 4B). In contrast, high levels of IFN-y were obtained from the recall 
responses of L. major-infected mice challenged with L. major Ag. To determine if the CD4+ 
T cells present in L. amazonensis-infected mice responded to the IL-12 treatment by altering 
Thl/Th2 transcription factor gene expression, real-time RT-PCR was used to analyze T-bet 
and GATA-3 mRNA expression in CD4+ T cells purified from the LN draining the site of Ag 
challenge. The presence of IL-12 at the time of in vivo restimulation did significantly 
enhance the T-bet to GATA-3 mRNA ratio over Ag-challenged L. amazonensis-mfected 
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mice, but it was still significantly less than the ratio observed in L. major-infected mice 
challenged with Ag (Figure 4C). Data was expressed as the ratio of T-bet to GATA-3 
mRNA as a previous study has shown that the relative expression of T-bet and GATA-3, 
rather than the expression of either transcription factor alone, was found to be more 
representative of the Thl/Th2 cytokine balance in a mixed population of cells (5). The more 
abundant GATA-3 mRNA expression than T-bet in the LN draining the site of Ag challenge 
results in a T-bet to GATA-3 mRNA ratio of less than one. However, this phenomenon is 
true for all samples, including the CD4+ T cells from L. major-infected mice that have a 
productive Thl response. These results indicate that CD4+ T cells from L. amazonensis-
infected mice can respond to Ag and IL-12 in vivo by enhancing accumulation. 
Additionally, an enhanced T-bet to GATA-3 mRNA ratio in CD4+ T cells draining the site of 
Ag challenge from L. amazonensis-'mÎQCtQà mice is observed when IL-12 is present at the 
time of in vivo Ag stimulation, although it is unclear as to how IL-12 is influencing T-bet 
mRNA in these experiments. Taken together, our data indicate that the absence of IL-12 in 
vivo during Ag stimulation is not the sole reason for inefficient IFN-y production from CD4+ 
T cells present during L. amazonensis infection. 
CD4+ T cells from L. amazonensis-infected mice have limited responsiveness to IL-12 in 
vitro. 
Since other cells types including APCs may influence the function of CD4+ T cells, 
we wanted to determine if APCs from non-infected mice with or without IL-12 could 
promote a Thl effector phenotype in T cells comparable to that of T cells derived from 
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Figure 4. CD4+ T cells present in L. amazonensis-infected mice respond to Ag but exhibit 
limited IL-12 responsiveness in vivo. Mice that had been infected in the left hind footpad 
with L. amazonensis for ten weeks were injected in the right (uninfected) hind footpad with 
either PBS, L. amazonensis Ag or Ag and IL-12; L. major-infected mice were challenged in 
their uninfected footpad with L. major Ag. After 48 h post-Ag challenge, LN cells draining 
the site of Ag challenge were harvested and (A) analyzed via flow cytometry for the 
percentage of CD44hl CD4+ T cells present in the LN after Ag challenge. * represents a 
statistically significant difference between the indicated treatments at p < 0.05 as determined 
by a paired t test. (B) LN cells draining the site of Ag challenge were stimulated for three 
days in the presence (Ag Stim) or absence (No Stim) of 50 [xg/ml of their respective Ag as 
described in Figure 2A; supernatants were assayed for IFN-y via ELISA. * represents a 
statistically significant difference between No Stim and Ag Stim within a group at p < 0.05 
as determined by a paired t test. ** represents a statistically significant difference from all 
other groups at p < 0.05 as determined by Fisher's PLSD test. (C) CD4+ T cells were 
purified from the LN draining the site of Ag challenge and analyzed via real-time RT-PCR 
for T-bet and GATA-3 mRNA expression. Data are expressed as the ratio of T-bet to 
GATA-3 mRNA after each target had been normalized to GAPDH. * represents a 
statistically significant difference between Ag and Ag + IL-12 within a group at p < 0.05 as 
determined by a paired t test. ** represents a statistically significant difference from all other 
groups at p < 0.05 as determined by Fisher's PLSD test. All data are represented as the mean 
+ the SEM of two (C) to three (A & B) separate experiments. 
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L. mq/or-infected mice in vitro. We purified CD4+ T cells from the DLN of infected mice 
and co-cultured those cells with Ag-pulsed, mitomycin C-treated splenocytes from naïve 
mice for five days; the production of effector cytokines was then quantified via ELISA. 
Under neutral conditions (no polarizing cytokines or antibodies), CD4+ T cells from L. 
amazonensis-infected mice produced significantly less IFN-y than those cells from L. major 
infected mice (Figure 5A). Under Thl conditions (anti-IL-4 and rIL-12), CD4+ T cells from 
L. amazonensis-infected mice did respond to IL-12 by enhancing their production of IFN-y in 
comparison to neutral condition values. Despite equivalent absolute numbers of CD44hl 
CD4+ T cells present in both L. amazonensis and L. major cultures, the CD4+ T cells from L. 
amazonensis-infected mice consistently produced only 10-15% of the IFN-y produced by the 
CD4+ T cells purified from L. major-infected mice stimulated under identical conditions 
(Figure 5B). These data indicate that although CD4+ T cells from L. amazonensis-infected 
mice can respond to IL-12 in vitro, intrinsic defects prevent them from developing a Thl 
phenotype equivalent to that of CD4+ T cells derived from L. major infected mice. 
Discussion 
In this study, we extend our understanding of the dysfunctional immune response 
associated with the high parasite load and persistent lesion that characterizes the chronic 
stage of L. amazonensis infection in immunocompetent mice. Our data indicate that the 
immune response consists of an Ag-responsive CD4+ T cell population that expresses CD44, 
proliferates and produces IL-2 as well as their counterparts from L. major-infected mice 
(Figures 1C and 2). However, the CD44hl CD4+ T cell population from L. amazonensis-
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Figure 5. CD4+ T cells from L. amazonensis-infected mice have limited responsiveness to 
IL-12 in vitro. At 10 weeks p.i., 1 x 105 CD4+ T cells from the DLN of infected mice were 
stimulated with 50 pig/ml of their respective Ag as described in Figure 2A and co-cultured 
with 1 x 106 mitomycin C-treated splenocytes from naïve mice for 5 days under either (A) 
neutral (no polarizing cytokines or antibodies) or (B) Thl (rIL-12 and anti-IL-4) conditions. 
Supernatants were assayed for IFN-y via ELISA. Data are represented as the mean + the 
SEM of four separate experiments. * represents a statistically significant difference at p < 
0.05 as determined by Fisher's PLSD test. 
infected mice has an unskewed effector phenotype as reflected by low levels of both Thl/Th2 
transcription factor mRNA expression, IFN-y and IL-4 protein expression (Figure 3) and a 
limited responsiveness to IL-12 (Figures 4 and 5). 
The ability of Ag-responsive CD44hl CD4+ T cells from L. amazonensis-'mfected mice 
to proliferate as efficiently as cells derived from L. major infected animals was surprising, as 
previous works have indicated a suppressed proliferative response in comparative studies 
(13, 15). These differences may be a result of assessing proliferation at different time points 
during infection, whereas the current studies were performed exclusively during the 
established chronic phase of disease. Other factors that may influence the proliferative 
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response of these cells could include Ag preparation and the amount of Ag used in re-
stimulation. The phenomenon of cell death could also account for these different 
observations as a loss of live cells in culture would not influence the results of our analysis 
using CFSE labeling but would lead to decreased tritiated thymidine incorporation. 
This current report of an uncommitted CD4+ T cell phenotype during L. amazonensis 
infection complements previous studies in which a mixed Thl/Th2 response was observed 
throughout the course of L. amazonensis infection (1, 12). Our studies specifically 
characterize an Ag-responsive subpopulation of CD4+ T cells from L. amazonensis-infected 
mice with low mRNA expression levels of the Thl transcription factor, T-bet, in comparison 
to similar cells from L. ma/'or-infected mice. These findings describe a specific defect in the 
T cell activation pathway that can account for the previously described inefficient IFN-y 
production and low levels of IL-12Rp2 mRNA expression observed from CD4+ T cells 
during L. amazonensis infection ((13, 15) and in results). Moreover, we show that CD44hl 
CD4+ T cells from L. amazonensis- and L. mq/or-infected mice both express similar levels of 
GATA-3 mRNA and IL-4 intracellular staining, indicating that this T cell population is also 
not biased towards a Th2 response. Interestingly, CD44hl CD4+ T cells from uninfected mice 
express more GATA-3 mRNA than those cells from L. amazonensis-mfecled mice (Figure 
3B). These observations are consistent with the phenomenon that GATA-3 mRNA 
transcripts are high in naïve cells and then either decrease as cells polarize toward a Thl 
phenotype or remain high if a Th2 phenotype is developed (8). Nonetheless, relatively low 
levels of GATA-3 and T-bet mRNA expression indicate that CD44hl CD4+ T cells from L. 
amazonensis-infected mice are a population that has not committed to either a Thl or Th2 
phenotype in vivo. 
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Previous work has indicated that mice infected with L. amazonensis fail to increase 
the number of IL-12-producing cells as compared to uninfected controls (15). To 
compensate for this deficit, we restimulated CD4+ T cells in vivo by injecting both IL-12 and 
Ag into the contralateral (uninfected) footpad of chronically infected mice to test the ability 
of this uncommitted cell population to differentiate towards a Thl population during antigen 
stimulation in the presence of IL-12. We observed a response to Ag by the CD4+ T cell 
population as indicated by an increased percentage of CD44hl CD4+ T cells in the lymph 
node draining the site of Ag challenge when compared to PBS-injected controls (Figure 4A). 
Despite observing an enhanced T-bet to GATA-3 mRNA ratio in the CD4+ T cells of L. 
amazonensis-infected mice challenged with Ag in the presence of IL-12, the production of 
IFN-y upon in vitro Ag-stimulation was unchanged (Figure 4B). One in vivo administration 
of IL-12 may not be sufficient to promote the development of a population of Thl CD4+ T 
cells, and previous work has suggested that CD4+ T cells from C3H mice with an acute L. 
amazonensis infection may be unable to respond to IL-12 due to low levels of IL-12RJ32 
mRNA expression (15). However, the limited in vitro IL-12 responsiveness observed in this 
study and the successful development of CD4+ T cells with a Thl phenotype by repeated 
administration of IL-12 with Ag-pulsed bone marrow-derived dendritic cells to mice 
chronically infected with L. amazonensis indicate that the CD4+ T cell population present 
during chronic L. amazonensis infection is able respond to IL-12 to some extent (26). The 
relatively low levels of IFN-y production both in vitro and in vivo in response to IL-12 
suggests that transition to a Thl phenotypic cell population is limited by intrinsic defects in 
the CD4+ T cells rather than simply the presence or absence of IL-12 during T cell activation. 
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Much attention has been given to the negative role of T regulatory (Treg) cells in 
infectious disease, where Treg cells limit productive immune responses and promote infection 
(reviewed in (4, 17)). However, recent work has shown that Treg cells are important in 
limiting the immunopathogenesis of L. amazonensis infection, although that beneficial effect 
is transitory (11). Previous work has shown that Treg cells are necessary for the establishment 
of a chronic L. major infection with accompanying low parasite load, and that Treg function 
was dependent on IL-10 (3). However, IL-10 knock-out mice infected with L. amazonensis 
still develop a chronic infection with a relatively high parasite load, suggesting that T cell-
derived IL-10 is not entirely responsible for limiting an effective immune response (14). 
Blocking TGF-|3 in BALB/c mice infected with L. amazonensis has been reported to 
facilitate healing (2). However, the effects of TGF-|3 are often conflicting, and may be due in 
part to its opposing effects on Thl development in various mouse strains (9). Blocking TGF-
P in vitro fails to enhance IFN-y production in CD4+ T cells isolated from L. amazonensis-
infected C3H mice ((15), Ramer and Jones unpublished observations). Taken together, these 
observations indicate that it is unlikely for Treg cells, IL-10 or TGF-|3 to be responsible for the 
lack of a Thl phenotype in CD4+ T cells during L. amazonensis infection. 
We believe that the limited effector functions of CD4+ T cells present in L. 
amazonensis-infected mice may result from a combination of priming by immature or semi-
mature dendritic cells and the presence of high antigen load. Chronic L. amazonensis 
infection is characterized by the absence of a robust inflammatory response, as evidenced by 
decreased IL-12 production and decreased mRNA expression of multiple inflammatory 
mediators and a high parasite load (13, 15, 26). Recent work has shown that inappropriately 
primed dendritic cells in vivo can support CD4+ T cell clonal expansion but cannot prime an 
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effector response (23). Indeed, some persistent infections, including HIV, are thought to 
limit dendritic cell maturation and thus induce peripheral tolerance due to Ag capture and 
presentation by immature dendritic cells (24). In addition, activation of CD4+ T cells in the 
presence of high viral load or providing multiple Ag stimulations to CD4+ T cells results in 
diminished CD4+ effector responses (6, 10). Dysfunctional CD8+ T cell responses have also 
been described in chronic lymphocytic choriomeningitis virus and Trypanosoma cruzi 
infections of mice, as these cells are activated yet exhibit attenuated IFN-y production and 
cytotoxic activity (16, 27). With these studies in mind, we suggest that chronic L. 
amazonensis infection could result from parasite resistance to macrophage killing which 
creates a persistent, high Ag load that impairs CD4+ T cell effector functions (7, 22). In turn, 
these dysfunctional T cells are incapable of promoting effective macrophage activation and 
subsequent parasite elimination. 
Altogether, our data indicate that mice with chronic L. amazonensis infections do 
possess an Ag-responsive CD44hl CD4+ T cell population that can proliferate and produce 
IL-2, but is impaired in the ability to efficiently produce IFN-y. These CD44hl CD4+ T cells 
have an unbiased pattern of Thl/Th2 transcription factor mRNA expression in vivo and 
cannot be effectively polarized towards a Thl phenotype either in vitro or in vivo in the 
presence of IL-12. Our observations implicate an impaired, unskewed CD44hl CD4+ T cell 
population as a factor contributing to the chronicity of L. amazonensis infection. 
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Chapter 3 
IL-2 limits IL-12 responsiveness of CD4+ T cells from Leishmania 
amazonensis-infected C3H mice in vitro 
Amanda E. Ramer and Douglas E. Jones 
A paper prepared for submission to the Journal of Immunology 
Abstract 
C3H mice infected with Leishmania major develop a polarized Thl response whereas 
infection with L. amazonensis creates a population of antigen-responsive, CD44hl CD4+ T 
cells that proliferate and produce IL-2 but do not polarize to an effector phenotype. Based on 
CD25 expression, CD44hl CD4+ T cells from L. amazonensis-infected mice exhibit a resting 
(CD25 negative) then activated (CD25 positive) effector phenotype after primary and 
secondary antigen (Ag) stimulations in vitro, respectively. Although multiple Ag 
stimulations in the presence of IL-12 yield equivalent percentages of IFN-y-producing 
CD44hl CD4+ T cells in cultures of T cells derived from L. amazonensis- and L. major-
infected mice, the total amount of IFN-y produced by T cells from L. amazonensis-infected 
mice is 40% less than that produced by T cells from L. major-infected mice. This deficit in 
IFN-y production results from a failure of CD44hl CD4+ T cells from L. amazonensis-infected 
mice to accumulate in culture. Unlike CD44hl CD4+ T cells from L. major-infected mice, 
CD44hl CD4+ T cells from L. amazonensis-infected mice did not exhibit enhanced 
proliferation in response to IL-2 or IL-12. However, neutralization of IL-2 mediates 
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enhanced proliferation of CD44hl CD4+ T cells from L. amazonensis-infected mice in 
response to IL-12. These results indicate that IL-2 suppresses enhanced proliferation in 
response to IL-12 for activated effector CD4+ T cells. 
Introduction 
When C3HeB/FeJ mice are infected with Leishmania major, they develop a classic 
Thl response characterized by the production of IFN-y. These mice subsequently heal their 
infections and are considered resistant to L. major infection. However, infection of these L. 
major-resistant mice with L. amazonensis results in chronic lesions that contain up to 108 
parasites and low to undetectable levels of both IFN-y and IL-4 in the recall responses of 
draining lymph node (DLN) cells. Susceptibility to L. amazonensis infection is not due to 
the presence of a Th2 response but rather to the absence of an effective Thl response. 
Previous work in our laboratory has shown that L. amazonensis-infected mice possess 
equivalent percentages of CD44hl CD4+ effector/memory T cells as do L. major-infected 
mice (1). This T cell population is Ag responsive but remains unskewed towards either a 
Thl or Th2 phenotype. While these T cells are able to enhance IFN-y production in response 
to IL-12, the amount of IFN-y produced is only 10-15% of that produced in L. major CD4+ T 
cell cultures. This work demonstrates that the failure of CD4+ T cells from L. amazonensis-
infected mice to become efficient Thl effector cells is due to factors beyond the presence or 
absence of IL-12. 
In this study, we continue to investigate the ability of the CD44hl CD4+ T cell 
population from L. amazonensis-infected mice to respond to IL-12. Previous work has 
demonstrated that CD44hl CD4+ T cells from L. amazonensis-infected mice produce IL-2 and 
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proliferate upon Ag stimulation (1); central memory CD4+ T cells exhibit a similar 
phenotype but are able to produce effector cytokines upon secondary Ag stimulation (2). 
Therefore, we also address the hypothesis that CD44hl CD4+ T cells from L. amazonensis-
infected mice may be a type of central memory cell requiring multiple Ag stimulations in 
order to produce IFN-y as efficiently as CD44hl CD4+ T cells from L. major-infected mice. 
We also report that CD44hl CD4+ T cells from L. amazonensis-infected mice exhibit a resting 
then activated phenotype after primary and secondary antigen stimulations, respectively, 
based on CD25 expression. While providing multiple antigen stimulations in the presence of 
IL-12 elicits equivalent percentages of IFN-y-producing CD44hl CD4+ T cells in cultures 
derived from L. amazonensis- and L. major-infected mice, it does not result in equivalent 
total amounts of IFN-y between the two cultures. Cell accumulation is limited in cultures of 
T cells derived from L. amazonensis-infected mice as compared to those of T cells derived 
from L. major-infected mice. CD44hl CD4+ T cells from L. major-infected mice exhibit 
enhanced proliferation in response to IL-12 whereas CD44hl CD4+ T cells from L. 
amazonensis-infected mice do not. However, IL-2 was found to suppress the IL-12-
dependent enhanced proliferation of activated effector CD4+ T cells from L. amazonensis-
infected mice. 
Materials and Methods 
Parasites and antigens. Culture of L. amazonensis (MHOM/BR/OO/LTBOO16) and L. major 
(MHOM/IL/80/Friedlin) and preparation of parasite antigens were performed as previously 
described (3). 
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Mice. Female C3HeB/FeJ mice (six to eight weeks of age) were either bred in-house or 
obtained from The Jackson Laboratory (Bar Harbor, ME) and maintained in a specific 
pathogen-free facility. Mice were injected with 5 x 106 stationary phase promastigotes in 50 
[0,1 PBS in the left hind footpad. Between four and seven mice were used per group for each 
experiment and were sacrificed at four weeks post-infection. The IACUC at Iowa State 
University approved all protocols involving animals. 
CD4+ T cell purification. CD4+ T cells were purified from lymph nodes via magnetic 
depletion (negative selection) using a biotin-conjugated antibody cocktail and anti-biotin 
MicroBeads (Miltenyi Biotec, Auburn, CA) according to the manufacturer's protocol. Cells 
were subjected to two passes through an AutoMACS cell sorter. The purity of the CD4+ T 
cells was routinely 90% or greater. 
Mini-double cultures. These minicultures were adapted from previously described protocols 
(4, 5) as a method to provide purified CD4+ T cells with both a primary and secondary in 
vitro stimulation. All cultures were performed in duplicate or triplicate in 96-well U-bottom 
plates and in a total volume of 200 fxl per well. 1 x 105 CD4+ T cells purified from the 
draining lymph node of either L. amazonensis- or L. major-infected mice were cultured with 
2 x 105 mitomycin C-treated, carboxyfluorescein diacetate succinimidyl ester- (CFSE) 
labeled naïve splenocytes and 50 [ig/ml freeze-thawed Leishmania promastigote Ag (CD4+ T 
cells isolated from L. ma/or-infected mice were stimulated with L. major Ag and CD4+ T 
cells isolated from L. amazonensis-infected mice were stimulated with L. amazonensis Ag) in 
complete tissue culture medium (CTCM; DMEM containing 4.5 mg of glucose/ml, 2 mM L-
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glutamine, 100 U penicillin, 100 pg streptomycin/ml, 25 mM HEPES, 0.05 pM 2-
mercaptoethanol and 10% fetal bovine serum). Feeder splenocytes were prepared by 
incubating spleen cells from naïve female C3HeB/FeJ mice with a lysing buffer (0.15 M 
ammonium chloride, 10 mM potassium bicarbonate and 0.1 mM ethylenediaminetetra-acetic 
acid) to lyse red blood cells. After red blood cells lysis, splenocytes were labeled using 
CFSE (Molecular Probes, Eugene, OR) as previously described (6) and then treated with 
mitomycin C (Sigma, St. Louis, MO) at a final concentration of 50 pg/ml at 37°C for 20 min 
and washed five times with an excess of CTCM before co-culture with purified CD4+ T cells. 
Cultures were maintained in the presence of no exogenous cytokine (neutral conditions), 2 
ng/ml IL-12 (Peprotech, Rocky Hill, NJ), 10 ng/ml IL-2 (Peprotech), 10 pg/ml anti-IL-2 
(S4B6, BD Pharmingen, San Diego, CA), 10 pg/ml control antibody (R35-95, Pharmingen) 
or various combinations thereof. CD4+ T cells were rested for 48 hrs on day 3 by removing 
100 pi of culture supernatant and replacing it with 100 pi of medium containing 2 x 105 fresh 
feeder splenocytes without Ag and, depending on the culture conditions, cytokine or antibody 
at the final concentrations described above. CD4+ T cells were given a secondary 
restimulation on day 5 by removing 100 pi of culture supernatant and replacing it with 100 pi 
of medium containing 2 x 105 fresh feeder splenocytes with 20 pg/ml Ag and, depending on 
the culture conditions, cytokine or antibody at the final concentrations described above. 
Cultures were analyzed by flow cytometry or BrdU ELISA either 24 hrs or 3 days after the 
secondary stimulation. Culture supernatants were removed for IFN-y ELISA on day 3 after 
the secondary stimulation. To determine the number of live CD44hl CD4+ T cells in culture 
as an assessment of cell accumulation, a known number of washed, surfactant-free white 
sulfate latex beads (Interfacial Dynamics Corporation, Portland, OR) were added to each well 
prior to harvest. Cells were stained and analyzed via flow cytometry as described below. A 
bead ratio was generated by dividing the number of beads collected during FACS acquisition 
by the number of beads added to the well. The number of live CD44hl CD4+ T cells collected 
was determined using a typical live lymphocyte gate and then divided by the bead ratio to 
calculate the number of live CD44hl CD4+ T cells present in each culture well. 
Flow cytometry. To evaluate intracellular IFN-y 24-hr after secondary stimulation, T cells 
were stimulated with PMA (50 ng/ml) and ionomycin (50 ng/ml) in the presence of brefeldin 
A (10 pg/ml) for 6 hrs prior to harvest. Cells were harvested, washed, stained with 
Cychrome-labeled anti-CD44 (IM7, Pharmingen) or the appropriate isotype controls and 
fixed. Intracellular IFN-y was assayed using PE-labeled anti-IFN-y (XMG1.2, Pharmingen) 
as previously described (6). Cells were acquired on a FACScan flow cytometer (Becton 
Dickinson, San Jose, CA) and data were analyzed using Flowjo software (Tree Star, Ashland, 
OR). For all samples analyzed via flow cytometry, the CFSE-labeled feeder layer was 
excluded from the analysis of the purified CD4+ T cells from infected mice. Surface staining 
for CD25 (PC61, eBioscience, San Diego, CA) was performed as previously described (3). 
To evaluate BrdU incorporation 3 days after primary stimulation or 24-hr after secondary 
stimulation, T cells were pulsed with 50 mM BrdU (Sigma) during the last 12 hrs of culture. 
Cells were then harvested, surface stained and fixed as described in (3). Following washes in 
FACS buffer (0.1% BSA and 0.1% sodium azide in PBS) and FACS buffer with 0.1% 
saponin, cells were incubated with 10 U of DNase I (Pierce Biotechnology, Rockford, IL), 
0.15 M NaCl and 2.4 mM MgClz in 100 pi volume at 37°C for 1 hr. Cells were washed 
again in FACS buffer with saponin and stained using the PE-labeled anti-BrdU antibody set 
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(Pharmingen) according to manufacturer's protocol. Cells were washed again in FACS 
buffer with saponin and then FACS buffer before acquisition. 
ELISAs. Supernatants were assayed via ELISA for IFN-y; sensitivity ranged between 39 and 
156 pg/ml. All IFN-y ELISA antibodies were purchased from Pharmingen and used 
according to manufacturer recommendations. Ag-pulsed mitomycin C-treated splenocytes 
alone were cultured under similar conditions as CD4+ T cells to determine baseline amount 
of cytokine production. BrdU ELISAs were conducted using the Cell Proliferation BrdU 
Colorimetric ELISA Kit (Roche Applied Science, Indianapolis, IN). Cultures were pulsed 
with 10 mM BrdU for 12 hrs and then transferred to flat-bottom 96-well plates before 
continuing with the manufacturer's protocol. Ag-pulsed mitomycin C-treated splenocytes 
alone were cultured under similar conditions as CD4+ T cells to determine baseline amount 
of BrdU incorporation. For some primary stimulation cultures, tyrphostin AG490 (LC 
Laboratories, Woburn, MA) was added 24 hrs prior to harvest in the amounts indicated in the 
figure legend to inhibit Jak2 and/or Jak3 signaling. 
Statistical Procedure. Statistical analysis was performed using Statview (SAS, Cary, NC). 
When treatment groups were compared, the data were analyzed with the Scheffe's post-hoc 
test. When two treatments within a group were compared, data were analyzed using a paired 
t-test. Differences were considered significant when p < 0.05. 
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Results 
Providing multiple in vitro Ag stimulations to CD4 T cells from L. amazonensis-
infected mice does not enhance IFN-y production to levels equivalent to that of CD4+ T 
cells from L. mayor-infected mice. 
We have previously reported that L. amazonensis-infected mice possess a population 
of antigen-responsive CD44hl CD4+ T cells that proliferate and produce IL-2 but is not 
skewed towards either a Thl or Th2 phenotype. Moreover, this population of T cells does 
not produce IFN-y as efficiently as T cells isolated from L. major-infected mice following in 
vitro Ag stimulation in the presence IL-12 (1). Over the past few years, several studies have 
characterized central memory CD4+ T cells—cells that, upon Ag-restimulation, proliferate 
and produce IL-2, but do not produce effector cytokines until a second Ag stimulation is 
provided (reviewed in (2)). To determine if the CD44hl CD4+ T cells present in L. 
amazonensis-infected mice are a type of central memory T cell population, multiple in vitro 
Ag stimulations were provided to purified CD4+ T cells from L. amazonensis-infected mice 
using a previously described protocol with some modifications (5). Briefly, CD4+ T cells 
were purified from the DLN of mice at 4 wks post-infection and co-cultured with mitomycin 
C-treated splenocytes from naïve mice (an APC feeder layer) and Ag for a primary Ag 
stimulation. CD4+ T cells were rested on day 3 of culture by adding fresh APC feeder cells 
without Ag. A secondary stimulation was provided on day 5 of culture using fresh Ag-
pulsed APC feeder cells. Because CD44hl CD4+ T cells are present in equivalent percentages 
ex vivo in both L. amazonensis- and L. major-infected mice (1), each well began the culture 
period with the same number of CD44hl CD4+ T cells. CD4+ T cells from L. major-infected 
mice were used as a benchmark for a productive Thl response. Following a second Ag 
stimulation, the percentage of CD44hl CD4+ T cells producing IFN-y in cultures of T cells 
isolated from L. amazonensis-infected mice was only 32% of the percentage of CD44hl CD4+ 
T cells producing IFN-y in cultures of T cells isolated from L. m a/or-infected mice (Figure 
1A). Also, the amount of IFN-y detected in the culture supernatants of T cells from L. 
amazonensis-infected mice was only 29% of that detected in the culture supernatants of T 
cells from L. major-infected mice (7.0 + 2.1 ng/ml and 24.0 + 6.4 ng/ml, respectively). 
These data indicate that a second Ag stimulation is not sufficient to enhance IFN-y 
production from CD44hl CD4+ T cells isolated from L. amazonensis-infected mice to levels 
equivalent to CD44hl CD4+ T cells from L. major-infected mice. 
A possible explanation for the enhanced IFN-y production of CD44hl CD4+ T cells 
from L. major-infected mice could be that these cells have an enhanced activation status. To 
address this, we examined expression of the high-affinity IL-2 receptor (CD25) on CD44hl 
CD4+ T cells from Leishmania-infected mice. Ex vivo, 20% of the CD44hl CD4+ T cells 
from L. amazonensis- and L. major-infected mice were CD25+ (Figures IB & C). That 
percentage did not increase significantly after a 3-day primary Ag-stimulation in vitro. After 
the 2-day rest, however, the percentage of CD25+ CD44hl CD4+ T cells more than doubled 
for both cultures and continued to increase during the secondary stimulation. Three days 
after the secondary restimulation, over 80% of the CD44hl CD4+ T cells were CD25+ in both 
cultures; however, the mean fluorescence intensity (MFI) of CD25 expression on CD44hl 
CD4+ T cells from L. amazonensis cultures was 237 + 8.2 while those cells from L. major 
cultures had an MFI of 100 + 5.7 (Figure ID). These data indicate that, based on CD25 
expression, CD44hl CD4+ T cells from L. amazonensis-infected mice exhibit a resting (CD25 
negative) then activated (CD25 positive) effector phenotype after primary and 
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secondary in vitro Ag stimulations, respectively. Neutralizing IL-2 in vitro significantly 
reduced CD25 expression for CD44hl CD4+ T cells from L. amazonensis-infected mice while 
the addition of exogenous IL-2 to the cultures significantly increased CD25 expression on 
CD44hl CD4+ T cells from L. major-infected mice (Figures IE & F). Together, these data 
describe a population of CD4+ T cells from L. amazonensis-infected mice that sustain high, 
IL-2-dependent expression of CD25 following a secondary Ag stimulation. 
CD44hl CD4+ T cells from L. amazonensis-infected mice enhance IFN-y production in 
response to IL-12 but fail to accumulate in culture as well as those from L. major-
infected mice. 
Previous work from our lab evaluated IL-12 responsiveness of CD4+ T cells after a 
primary Ag stimulation, which would correspond to T cells with a resting effector phenotype, 
and showed that CD4+ T cells from L. amazonensis-infected mice cultured in vitro in the 
presence of IL-12 and Ag produced only 10-15% of the IFN-y produced by L. major CD4+ T 
cells cultured under identical conditions (1). Given the different activation status of CD44hl 
CD4+ T cells during the primary and secondary stimulations, we wished to assess IL-12 
responsiveness of activated effector cells during the secondary Ag stimulation. After 
maintaining CD4+ T cells in IL-12 throughout the entire culture period, the overall amount of 
IFN-y produced by T cells isolated from L. amazonensis-infected mice was enhanced in 
response to IL-12, increasing from 7 ng/ml to 65 ng/ml, but that amount was only 55% of the 
IFN-y produced by T cells isolated from L. major-infected mice (Figure 2A). The percentage 
of CD44hl CD4+ IFN-y+ T cells, however, was equivalent in the presence of IL-12 (Figure 
2B). Mean fluorescence intensities were also similar between both cultures, indicating 
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similar amounts of IFN-y were being produced per CD44hl CD4+ T cell in response to IL-12 
in both L. amazonensis and L. major CD4+ T cell cultures (data not shown). These data 
indicate that although a second Ag stimulation in the presence of IL-12 is sufficient to elicit 
equivalent percentages of IFN-y-producing CD44hl CD4+ T cells in cultures of T cells 
derived from L. amazonensis- and L. major-infected mice, it does not result in equivalent 
absolute amounts of IFN-y in both cultures. 
One plausible explanation for this deficit in total IFN-y produced by T cells from L. 
amazonensis-infected mice in response to IL-12 could be the failure of CD44hl CD4+ T cells 
from L. amazonensis-infected mice to accumulate (including both to proliferate and survive) 
in culture. Cell accumulation was assessed using latex beads as described in materials and 
methods. The number of live CD44hl CD4+ T cells in the cultures of T cells derived from L. 
amazonensis-infected mice was found to be only 59% of the number present in the cultures 
of T cells from L. major-infected mice in the presence of IL-12 (Figure 2C). A similar 
phenomenon was observed under neutral conditions as the number of live CD44hl CD4+ T 
cells in the cultures of T cells derived from L. amazonensis-infected mice was found to be 
only 71% of the number present in the cultures of T cells from L. major-infected mice (data 
not shown). Considering that both cultures began with the same number of live CD44hl 
CD4+ T cells, this data indicates that CD44hl CD4+ T cells from L. amazonensis-infected 
mice do not accumulate in culture as well as those from L. major-infected mice. This 
phenomenon can account for the 60% deficit observed in the total amount of IFN-y produced 
by T cells from L. amazonensis-infected mice in response to IL-12. 
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Figure 2. CD44hl CD4+ T cells from L. amazonensis-infected mice enhance IFN-y 
production in response to IL-12 but fail to accumulate in culture as well as those from L. 
major-infected mice. CD4+ T cells were cultured in the presence of IL-12 as described in 
materials and methods. (A) Culture supernatants were harvested 3 days post-secondary Ag 
stimulation and assayed via ELISA. (B) T cells were harvested 24 hours post-secondary Ag 
stimulation and assayed via flow cytometry for CD44 and IFN-y expression. (C) T cells 
were harvested as in B and assayed via flow cytometry for CD44 expression. The number of 
CD44hl CD4+ T cells was determined as in materials and methods; number of CD44hl CD4+ T 
cells present in cultures of T cells from L. amazonensis-infected mice is expressed as a 
percentage of the number of CD44hl CD4+ T cells present in cultures of T cells from L. 
major-infected mice. For all panels, data are represented as the mean + the SEM of nine (A) 
or six (B & C) separate experiments. * represents a statistically significant difference at p < 
0.05 as determined by Scheffe's test. 
96 
Resting effector CD4+ T cells from L. major-infected mice respond to IL-12 and IL-2 by 
enhancing proliferation whereas cells from L. amazonensis-infected mice do not during 
primary Ag stimulation. 
CD44hl CD4+ T cells from L. amazonensis-mfected mice may fail to accumulate in 
vitro compared to T cells from L. major-infected mice either because of enhanced 
proliferation of L. major CD44hl CD4+ T cells or because CD44hl CD4+ T cells from L. 
amazonensis-mfected mice experience increased cell death in culture. ELISA analysis of 
BrdU incorporation during the last twelve hours of the 3-day primary stimulation revealed 
that the presence of IL-12 significantly increased the BrdU incorporation (47% increase) of T 
cells isolated from L. major-infected mice (Figure 3A). While the presence of IL-12 also 
significantly increased BrdU incorporation in cultures of T cells from L. amazonensis-
mfected mice, the increase was only 18% greater than cultures with no IL-12. An analysis of 
BrdU incorporation via flow cytometry during the last twelve hours of the 3-day primary Ag 
stimulation revealed that the percentage of CD44hl CD4+ T cells from L. major-infected mice 
incorporating BrdU increased almost two-fold in response to IL-12 while CD44hl CD4+ T 
cells from L. amazonensis-mfected mice failed to exhibit any enhanced proliferation in the 
presence of IL-12 (Figure 3B), indicating that the slight increase observed in BrdU 
incorporation as assessed via ELISA could likely be attributed to improved cell survival 
rather than proliferation. Proliferation was equivalent between T cells from L. amazonensis-
and L. major-infected mice in neutral conditions (no addition of exogenous cytokines) when 
assessed by both ELISA and flow cytometry. Together, this data demonstrates that CD44hl 
CD4+ T cells from L. major-infected mice respond to IL-12 in vitro by enhancing 
proliferation whereas those cells from L. amazonensis-infected mice do not. 
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Figure 3. CD44hl CD4+ T cells from L. amazonensis-'mîccted mice are non-responsive to 
IL-2 and IL-12. (A) Cells were cultured in the presence or absence of IL-12 for 3 days post­
primary Ag stimulation and pulsed with BrdU during the final 12 hours of culture. BrdU 
incorporation was assessed via ELISA. (B) Cells were cultured as in A. CD44 expression 
and BrdU incorporation were assessed via flow cytometry. (C) Cells were cultured in the 
presence or absence of IL-2 or (D) with either a neutralizing antibody against IL-2 or a 
control antibody for 3 days post-primary Ag stimulation and pulsed with BrdU during the 
final 12 hours of culture. BrdU incorporation was assessed via ELISA. For all panels, data 
are represented as the mean + the SEM of four (A, C & D) or six (B) separate experiments. * 
represents a statistically significant difference between treatments within a group at p < 0.05 
as determined by paired t test. 
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Considering IL-2 has been described as a T cell proliferative factor in vitro (reviewed 
in (7)), we assessed the effect of IL-2 on proliferation of T cells from Leishmania-infected 
mice during the primary Ag stimulation. T cells were maintained in the presence of IL-2 
throughout the entire culture period, and BrdU incorporation during the last twelve hours of 
the 3-day primary Ag stimulation was assessed via ELISA. The addition of exogenous IL-2 
to cultures of T cells derived from L. major-infected mice resulted in a significant increase in 
BrdU incorporation (49% increase) over neutral conditions (Figure 3C). While not 
significant (p = 0.062), a 25% increase in BrdU incorporation was observed for T cell 
cultures isolated from L. amazonensis-mfected mice in response to IL-2. Neutralization of 
IL-2 in cultures of T cells isolated from L. major-infected mice T cells decreased BrdU 
incorporation by 32% while only decreasing BrdU incorporation by 17% in cultures of T 
cells from L. amazonensis-infected mice (Figure 3D). Altogether, these data indicate that 
resting effector T cells from L. amazonensis-mfected mice are less responsive to both IL-2 
and IL-12. 
Cytokine-mediated proliferation primarily involves the Jak-STAT pathway. While it 
is well documented that Jak3 plays a critical role in activating Stat5 proteins via IL-2 
(reviewed in (8)), the mechanism by which IL-12 promotes proliferation is less understood. 
Some reports indicate that IL-12 can signal through Jak2 and STATS to promote 
proliferation (9, 10). Despite the decreased responsiveness of L. amazonensis CD4+ T cells 
to IL-2 and IL-12, these cells still exhibit a basal level of proliferation in the presence of 
these cytokines. We wished to determine if CD4+ T cells from L. amazonensis-mfected mice 
still require Jak2 and Jak3 for proliferation. AG490 is a member of the synthetically derived 
family of tyrosine kinase inhibitors (11-13). At low doses (1 to 25 (-iM), AG490 inhibits Jak2 
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signaling and at higher doses (> 25 |iM), it inhibits both Jak2 and Jak3 signaling (13, 14). 
AG490 does not inhibit other known lymphocytic tyrosine kinases such as Lck, Lyn, Btk, 
Syk, Src, Jakl or Tyk2 (13). AG490 was added to CD4+ T cells from L. amazonensis- and L. 
major-infected mice cultured in the presence of IL-12. Proliferation was assessed via ELISA 
for BrdU incorporation. Proliferation in response to IL-12 by CD4+ T cells from L. major-
infected mice appeared to not be mediated by Jak2, as there was no significant decrease in 
BrdU incorporation compared at low doses of AG490 as compared to the DMSO control 
(Figure 4B). High doses of AG490 significantly decreased proliferation for CD4+ T cells 
derived from both L. amazonensis- and L. major-infected mice (Figures 4A & B). The 
similar response curves for cultures of T cells from both L. amazonensis- and L. major-
infected mice suggest that Jak3 is an important mediator of proliferation for resting effector 
CD4+ T cells from both L. amazonensis- and L. major-infected mice. These data also 
indicate that even though CD4+ T cells from L. amazonensis-infected mice respond poorly to 
IL-2, they still utilize Jak3 to help mediate proliferation, perhaps in response to another 
member of the common gamma chain family of cytokines. 
IL-2 limits enhanced proliferation in response to IL-12 for activated effector CD4 T 
cells present during secondary Ag stimulation. 
Synergy between IL-2 and IL-12 in terms of IFN-y production and proliferation has been 
described (15, 16). During secondary stimulation, IL-2 and IL-12 act in concert to promote 
IFN-y production from activated effector CD4+ T cells isolated from L. amazonensis-infected 
mice (Figure 5A). Despite this synergy, the IFN-y produced by CD4+ T cells from L. major-
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Figure 4. Jak3 is involved in proliferation of CD4+ T cells from L. amazonensis-infected 
mice. CD4+ T cells from L. amazonensis- (A) or L. major-infected mice (B) were cultured 
with IL-12 as described in materials and methods for 3 days post-primary Ag stimulation. 
AG490 or DMSO alone was added during the final 24 hours of culture; cells were pulsed 
with BrdU during the final 12 hours of culture. BrdU incorporation was assessed via ELISA. 
Data are represented as the mean + the SEM of three separate experiments. * represents a 
statistically significant difference from the DMSO control treatment at p < 0.05 as 
determined by paired t test. 
infected mice is still significantly more than is produced by CD4+ T cells from L. 
amazonensis-infected mice (data not shown). As in the primary stimulation, CD44hl CD4+ T 
cells from L. amazonensis assayed during the secondary stimulation for BrdU incorporation 
are still non-responsive to both IL-2 and IL-12 in terms of enhanced proliferation (Figure 
5C). BrdU incorporation is significantly decreased in the presence of both IL-2 and IL-12 
during the secondary stimulation. However, neutralization of IL-2 promotes enhanced 
proliferation of CD44hl CD4+ T cells from L. amazonensis-infected mice in response to IL-12 
(Figure 5D), but it does not limit IFN-y production in response to IL-12 (Figure 5B). CD4+ T 
cells from L. amazonensis-infected mice maintained in the presence of IL-2, IL-12 or IL-2 
plus IL-12 throughout the entire culture period significantly increased cell accumulation 
while neutralization of IL-2 throughout the entire culture period significantly decreased cell 
accumulation (Figures 5C &D), indicating that these cytokines may promote cell survival 
since they do not enhance proliferation. Taken together, these results indicate that IL-2 
suppresses enhanced proliferation but not enhanced IFN-y production in response to IL-12 in 
activated effector CD4+ T cells. 
Discussion 
The results reported in this study extend our understanding of the CD44hl CD4+ T cell 
population present during L. amazonensis infection. While previous work has demonstrated 
that this cell population is capable of Ag responsiveness, proliferation and IL-2 production, it 
remains unskewed towards either a Thl or Th2 phenotype. Additionally, IL-12 enhanced the 
IFN-y production of these CD4+ T cells, albeit limited, demonstrating that the failure of CD4+ 
T cells from L. amazonensis-infected mice to become efficient Thl effector cells is due to 
factors beyond the presence or absence of IL-12 (1). The data presented in this study 
indicate that IL-2 may be a factor involved in limiting the immune response during L. 
amazonensis infection as it limits enhanced proliferation of CD44hl CD4+ T cells in response 
to IL-12. 
In this present study, we find that multiple in vitro Ag stimulations fail to promote 
equivalent IFN-y production between CD4+ T cells from L. amazonensis- and L. major-
infected mice, indicating that the CD44hl CD4+ T cell population present in L. amazonensis-
mfected mice does not exhibit the functional characteristics of central memory CD4+ T cells. 
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Figure 5. IL-2 suppresses enhanced proliferation in response to IL-12 for activated effector 
CD4+ T cells from L. amazonensis-infected mice. CD4+ T cells were cultured as described in 
materials and methods in (A) the presence or absence of IL-2, IL-12 or IL-2 and IL-12 or (B) 
with a neutralizing antibody against IL-2 or a control antibody in the presence or absence of 
IL-12. Culture supernatants were harvested 3 days post-secondary Ag stimulation and 
assayed for IFN-y via ELISA. Data are represented as the mean + the SEM of three separate 
experiments. Treatments with different letters are significantly different from one another at 
p < 0.05 as determined by Scheffe's test. (C & D) Cells were cultured as described in A & 
B. To assess proliferation, cells were pulsed with BrdU during the final 12 hours of culture; 
BrdU incorporation was assessed via ELISA 24 hours post-secondary Ag stimulation. To 
assess cell numbers, the number of live CD44hl CD4+ T cells was determined as described in 
materials and methods; this procedure was performed to ensure that enhanced BrdU 
incorporation was indicative of enhanced proliferation and not a result of greater numbers of 
cells in culture. Data are represented as the mean + the SEM of three separate experiments 
except for treatment with IL-2 plus IL-12, which is two experiments. * represents a 
statistically significant difference at p < 0.05 as determined by Scheffe's test. 
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Instead, multiple Ag stimulations in the presence of IL-12 did yield equivalent 
percentages of IFN-y-producing CD44hl CD4+ T cells in both L. amazonensis and L. major T 
cell cultures. However, the total amount of IFN-y produced by T cells isolated from L. 
amazonensis-infected mice was 40% less than that produced by CD4+ T cells from L. major-
infected mice; a deficit that correlated with a failure of CD44hl CD4+ T cells from L. 
amazonensis-infected mice to accumulate in culture (Figure 2). In contrast to CD44hl CD4+ 
T cells from L. major-infected mice, CD44hl CD4+ T cells from L. amazonensis-infected 
mice are less responsive to both IL-2 or IL-12 (Figure 3). However, neutralization of IL-2 
allows enhanced proliferation of CD44hl CD4+ T cells from L. amazonensis-infected mice in 
response to IL-12 (Figure 5). Together, these results indicate that IL-2 suppresses enhanced 
proliferation in response to IL-12 for activated effector CD4+ T cells from L. amazonensis-
mfected mice, thus limiting CD44hl CD4+ T cell accumulation in vitro. 
Based on these data, the lack of equivalent amounts of IFN-y between L. amazonensis 
and L. major CD4+ T cell cultures can be explained by an IL-2-mediated reduction of in vitro 
accumulation of IFN-y-producing CD44hl CD4+ T cells from L. amazonensis-mfected mice. 
However, IL-2 neutralization does not enhance IFN-y production in the presence of IL-12 
relative to the control antibody-treated cultures (Figure 5B). We suggest that in an unskewed 
T cell population, such as that observed in L. amazonensis-infected mice, endogenously 
produced IL-2 functions to limit enhanced proliferation in response to IL-12, whereas in 
classical Thl cells, including those from L. major-infected mice, endogenously produced IL-
2 promotes IFN-y production. In fact, neutralization of IL-2 in the presence of IL-12 resulted 
in similar amounts of IFN-y produced by cultures of T cells from L. amazonensis- and L. 
major-infected mice (data not shown). This occurred not because of enhanced IFN-y 
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production by T cells from L. amazonensis-infected mice, but because neutralizing IL-2 in 
the presence of IL-12 significantly decreased the amount of IFN-y produced by CD4+ T cells 
from L. major-infected mice (data not shown). 
During the primary in vitro stimulation, two methods of assessing BrdU incorporation 
were employed. Because previous work via F ACS analysis demonstrated that greater than 
90% of CD4+ T cells incorporating BrdU were CD44hl, we chose to utilize the ELISA 
method for the majority of our BrdU incorporation experiments to increase the power of our 
analysis. Our BrdU ELISA results indicate that CD4+ T cells from L. amazonensis-infected 
mice are unresponsive to both IL-2 and IL-12. In contrast, a considerably greater increase in 
BrdU incorporation is observed for CD4+ T cells from L. major-infected mice in response to 
either IL-12 or IL-2 and more likely to represent both enhanced proliferation and survival. 
In order for IL-12 to promote IFN-y production, signal transduction through the IL-12 
receptor must result in phosphorylation of the Janus kinase Tyk2, which subsequently 
phosphorylates and activates signal transducer and activator of transcription 4 (STAT4) (17, 
18). In the current study, the ability of CD44hl CD4+ T cells from L. amazonensis-infected 
mice to enhance IFN-y production but not proliferation in response to IL-12 indicates that 
these two activities may be mediated by separate signaling pathways in this CD4+ T cell 
population which diverge downstream of the IL-12 receptor. Although previous reports 
indicate that IL-12 mediates its proliferative effects via Jak2 signaling (9, 10), our results do 
not support that observation for CD4+ T cells derived from L. major-infected mice (Figure 4). 
Instead, our data indicate a role for Jak3 in mediating proliferation of resting effector CD4+ T 
cells from both L. amazonensis- and L. major-infected mice in both the presence and absence 
of IL-12 (Figure 4 and data not shown). Jak3 is predominantly involved in mediating 
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proliferative signals from cytokines acting through receptors containing the gamma common 
chain. Our results indicate that proliferation of CD4+ T cells from L. amazonensis-infected 
mice may be mediated by a member of the common gamma chain family of cytokines 
including IL-7, IL-15 or IL-21, and may be independent of IL-2 (Figure 3) and IL-4 (data not 
shown). 
Our data demonstrates that CD44hl CD4+ T cells from both L. amazonensis and L. 
major-infected mice have low yet similar CD25 expression ex vivo and during the primary 
Ag stimulation and thus exist as "resting" effector cells during these periods. These CD44hl 
CD4+ T cells then transition to "activated" effector cells during the rest and secondary Ag 
restimulation as evidenced by their enhanced CD25 expression. Moreover, CD44hl CD4+ T 
cells from L. amazonensis-infected mice sustain a higher CD25 expression longer after 
secondary Ag restimulation than CD44hl CD4+ T cells from L. major-infected mice. 
Moreover, IL-2 regulates the expression of CD25 on CD44hl CD4+ T cells from L. 
amazonensis-infected mice, as neutralizing IL-2 decreases CD25 expression on these cells 
(Figure IE). IL-2 seems to have two opposing functions in T cell biology—potentiating T 
cell proliferation and terminating T cell responses. IL-2 has been described as a potent 
stimulator of naïve T cell growth and proliferation in vitro (7). More recently, however, its 
role in vivo has been described as one for maintaining tolerance instead of amplifying T cell 
responses. The primary mechanism by which IL-2 elicits its tolerogenic influence in vivo is 
via regulatory T (Treg) cells, most of which constitutively express the high affinity IL-2 
receptor (19, 20). IL-2 has also been shown to promote a stimulation refractoriness 
phenotype in activated CD4+ T cells cultured in vitro in the presence of IL-2 (21-23). T cells 
cultured continuously in the presence of IL-2 were found to be unresponsive to antigenic 
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restimulation for a period after initial stimulation (21); furthermore, these stimulation 
refractory T cells suppressed the proliferative response of naïve T cells much like 
c o n v e n t i o n a l  T r e g  c e l l s  ( 2 3 ) .  O u r  d a t a  s u g g e s t  t h a t  C D 4 4 h l  C D 4 +  T  c e l l s  f r o m  L .  
amazonensis-infected mice may experience a similar IL-2-mediated refractoriness following 
in vitro restimulation, as neutralization of IL-2 promotes enhanced proliferation in response 
to IL-12. Work by Norris et al demonstrates that the inhibitory effect of IL-2 is dependent 
upon the activation status of the T cell, as IL-2 promotes antigen reactivity of resting but not 
activated T cells (22). Unlike the T cells described by Norris et al, CD44hl CD4+ T cells from 
L. amazonensis-infected mice are non-responsive to both IL-2 and IL-12 as resting effector 
cells. This difference may result because our study utilized CD4+ T cells isolated from 
infected rather than naïve animals. Nevertheless, we also observed an inhibitory effect for 
IL-2 on activated T cells from L. amazonensis-mfected animals. 
Various models proposed by Grossman, Paul and colleagues predict that the strength 
and quality of an antigenic stimulation as well as the amount of antigen present during 
stimulation influence the behavior of a T cell. T cells possess different capacities for either 
self-renewal or differentiation—two competing cellular events that are regulated by recurrent 
interactions with antigen, APCs and other T cells (24-26). Under conditions of recurrent or 
continual antigen stimulation, effector cells may limit their own accumulation and 
differentiation by changing the balance between self-renewal and differentiation. The 
tunable activation threshold (TAT) model proposed by Grossman and Paul states that T cell 
activation is a threshold phenomenon and that the threshold is tuned by the stimulatory 
experience of the cell (25, 27). T cells are predicted to adapt to continuous or recurrent 
stimulation by updating their threshold for activation, thereby preventing resting T cells from 
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becoming activated effector cells in response to ambient interactions. Adaptively tolerant T 
cells have been shown to partially recapitulate this predicted behavior in vivo. Adaptively 
tolerant T cells are mature T cells that have adapted to persistent antigen stimulation by 
down-modulating (or tuning) their sensitivity to specific antigen restimulation (28). These T 
cells differentiate to various degrees and then down-regulate their production of effector 
cytokines, including IFN-y and IL-4, in the presence of persistent antigen (29, 30). Some 
characteristics of activation tuning by adaptively tolerant T cells can also be observed 
following certain persistent viral infections. Chronic lymphocytic choriomeningitis virus 
(LCMV) infection of mice has been shown to result in virus-specific CD8+ T cells that 
expressed activation markers and proliferated in vivo but were unable to elicit any antiviral 
effector functions (31, 32). We and others have observed impaired effector cytokine 
production of antigen-specific CD4+ T cells present during chronic infections such as those 
caused by L. amazonensis, hepatitis C virus, Mycobacterium tuberculosis, human 
immunodeficiency virus and gamma herpes virus (1, 33-36). 
In addition to Ag, cytokines can also influence the balance between self-renewal and 
differentiation (26). The presence of regulatory cytokines such as IL-10 or TGF-J3 can 
induce differentiation towards a suppressive or regulatory phenotype. These cytokines act 
upon and create tolerogenic antigen presenting cells, which then induce Treg cells. These Treg 
cells, in turn, suppress the proliferation and subsequent differentiation of other CD4+ T cells 
(37-39). Alternatively, an increase in the concentration of regulatory cytokines may act 
directly on the conventional antigen-specific T cells themselves, thereby conferring 
suppressive activity to those cells. This phenomenon could have a spreading (or 
"infectious") character, as these cells may recruit other T cells stimulated at the same time to 
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acquire a suppressor/regulatory function (26). We propose that high amounts of IL-2 exist 
during in vitro culture of CD44hl CD4+ T cells from L. amazonensis-infected mice. In turn, 
IL-2 prevents enhanced proliferation and accumulation of IL-12 responsive CD4+ T cells in 
the DLN. Due to the sustained, elevated expression of CD25 on CD44hl CD4+ T cells from 
L. amazonensis-infected mice, it is tempting to speculate that these T cells are a type of 
regulatory T cell. 
Chronic L. amazonensis infection is characterized by the absence of a robust 
inflammatory response, as evidenced by decreased IL-12 production and decreased mRNA 
expression of multiple inflammatory mediators (6, 40, 41), as well as by a high parasite load 
due to enhanced resistance of the parasite to macrophage-mediated killing (42, 43). We 
propose that the CD44hl CD4+ T cells present in vivo during L. amazonensis infection have 
adapted to the continual Ag stimulation by becoming tolerant, and that continual antigen 
stimulation due to the high parasite load present during infection promotes CD4+ T cell self-
renewal. IL-2 from unpolarized CD4+ T cells may in turn promote the development and 
survival of an antigen-specific regulatory T cell population that limits the differentiation and 
expansion of Thl CD4+ T cells even in the presence of IL-12. 
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Chapter 4 
Leishmania amazonensis-infected mice respond in vivo to exogenous IL-12 
by developing a Thl response but fail to create a population of antigen-
responsive IL-12-producing B cells 
Amanda E. Ramer and Douglas E. Jones 
A paper prepared for submission to Infection and Immunity 
Abstract 
Infection of C3H mice with Leishmania major results in a productive Thl response 
and the mice subsequently heal their infections. In contrast, infection of C3H mice with L. 
amazonensis creates chronic cutaneous lesions; a susceptible phenotype thought to result 
from an inability of these mice to develop a Thl response. We demonstrate that although 
administration of exogenous IL-12 to mice at the time of L. amazonensis infection promotes 
a Thl response at two weeks post-infection, these mice do not maintain that Thl response 
and fail to heal their infections. IL-12 is necessary for maintaining a Thl response, we 
examined whether or not administration of exogenous IL-12 and the subsequent Thl 
response that developed promoted endogenous IL-12 production. At two weeks post­
infection, IL-12p40 production is enhanced in draining lymph node cell cultures from IL-12-
treated L. amazonensis-infected mice compared to control mice, but by ten weeks post­
infection there is no difference between the two groups. We found that CD19+ B cells are a 
source of antigen-specific IL-12 during late L. major infection in contrast to CD19+ B cells 
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present during chronic L. amazonensis infection. IL-12 treatment does not promote a 
sustained source of antigen-specific IL-12 from B cells in these mice. Together, these results 
describe that the failure of IL-12-treated mice to heal their infections is not due to an inability 
to respond to IL-12 by developing a Thl response. Instead, the chronicity of L. amazonensis 
infection may result, in part, by a lack of sustained, antigen-specific IL-12 production from B 
cells. 
Introduction 
Experimental infection of inbred mice with various Leishmania spp. that cause 
cutaneous leishmaniasis has facilitated an understanding of some of the immune mechanisms 
necessary for control of these intracellular protozoan parasites. C3HeB/FeJ and C57BL/6 
mice are able to control an L. major infection by developing a Thl response, including both a 
sustained source of IL-12 and IL-12-responsive CD4+ T cells that upregulate the IL-12 
receptor |32 (IL-12R|32), express the Thl-associated transcription factor, T-bet, and produce 
IFN-y (13, 15, 24, 37). These mice ultimately heal their cutaneous lesions, which contain 
very few parasites by ten weeks post-infection (reviewed in (26, 28)). Infection of 
C3HeB/FeJ and C57BL/6 mice with L. amazonensis, however, results in chronic cutaneous 
lesions that contain up to 108 parasites by ten weeks post-infection and low to undetectable 
levels of both IFN-y and IL-4 in the in vitro recall responses of draining lymph node (DLN) 
cells (1, 14, 17). The susceptible phenotype of these mice is described as a lack of a 
productive Thl response rather than the presence of a Th2 response, as IL-4 and IL-10 
knock-out mice fail to heal their infections (16, 17). 
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The development of a Thl response is dependent upon the presence of IL-12 and the 
ability of CD4+ T cells to respond to IL-12 (10, 35, 36). Previous work has found that 
draining lymph node cells from L. amazonensis-infected mice produced low amounts of IL-
12 when compared with those from L. major-infected mice and that they fail to express a 
functional IL-12R (17). That same study also showed that administration of IL-12 to L. 
amazonensis-infected mice at the time of infection does not promote healing, presumably 
because of the failure to upregulate IL-12RJ32 (17). A subsequent study has demonstrated 
that mice chronically infected with L. amazonensis can respond to IL-12 when administered 
with antigen-pulsed bone marrow-derived dendritic cells as determined by enhanced T-bet 
and IL-12RJ32 mRNA expression (38). This data suggests that the failure of IL-12-treated L. 
amazonensis-infected mice to heal is not due solely to an inability to respond to IL-12. In 
this study, we have further investigated the IL-12 responsiveness of CD4+ T cells during in 
vivo administration of exogenous IL-12 and infection with L. amazonensis. 
We provide evidence that L. amazonensis-infected mice treated with IL-12 at the 
initiation of infection do develop a CD4+ Thl response similar to that of L. major-infected 
mice, yet this response is not maintained and the mice subsequently fail to heal their 
infection. Also in this study, we demonstrate that CD19+ B cells are a source of antigen-
specific IL-12 during chronic L. wq/or-infection. Although IL-12 treatment of L. 
amazonensis-infected mice promoted early endogenous IL-12 production by predominantly 
CDllc+ cells, these mice failed to develop a population of B cells that produced IL-12 in 
response to antigen (Ag). Our results indicate that the failure of L. amazonensis-infected 
mice treated with exogenous IL-12 to heal is not due to an inability of the CD4+ T cells to 
respond to IL-12 or to an inability of CD 11 c+ cells to produce IL-12. Instead, chronic 
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infection may result, in part, because these mice fail develop a population of Ag-responsive, 
IL-12-producing B cells to help maintain the Thl response. 
Materials and Methods 
Parasites and antigens. Culture of L. amazonensis (MHOM/BR/OO/LTBOOI6) and L. major 
(MHOM/IL/80/Friedlin) and preparation of promastigote parasite antigens were performed 
as previously described (16). For amastigote parasite antigens, amastigotes were isolated 
from the footpads of infected C3H SCID mice, washed three times in PBS, re suspended in 
PBS, sonicated and subjected to three freeze-thaw cycles consisting of -80°C and 37°C. 
Protein concentration was determined using the bicinchoninic acid assay, final concentration 
was adjusted to 1 mg/ml and aliquots were stored at -80°C until use. In all experiments 
involving Ag stimulation, cells were stimulated with the matching freeze-thawed 
promastigote Ag. The parasite burden of infected footpads was determined using a limiting 
dilution assay as previously described (1) and expressed as the negative log of parasite titer. 
Mice. Female C3HeB/FeJ mice (six to eight weeks of age) were either bred in-house or 
obtained from The Jackson Laboratory (Bar Harbor, ME) and maintained in a specific 
pathogen-free facility. Mice were infected with 5 x 106 stationary phase promastigote s in 50 
ill PBS in the left hind footpad. At the time of infection, some L. amazonensis-infected mice 
were also injected with 0.2 pig of IL-12 (Peprotech, Rocky Hill, NJ). These mice received 
0.2 pig of IL-12 in 25 |il of PBS intralesionally every other day for two weeks (a total of six 
injections) while control L. amazonensis- and L. mayor-infected mice received PBS injections 
of 25 pil. Lesion size was monitored with a dial micrometer and expressed as the difference 
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in footpad thickness between the infected and uninfected feet. Between three and five mice 
were pooled per group for each experiment and were sacrificed at either two or ten weeks 
post-infection as indicated in the figure legends. The IACUC at Iowa State University 
approved all protocols involving animals. 
Flow cytometry. To evaluate intracellular IFN-y, 1 x 106 draining lymph node (DLN) cells 
were plated per well in a 96-well U-bottom plate with 50 pig/ml of Ag in complete tissue 
culture medium (CTCM; DMEM containing 4.5 mg of glucose/ml, 2 mM L-glutamine, 100 
U penicillin, 100 pig streptomycin/ml, 25 mM HEPES, 0.05 piM 2-mercaptoethanol and 10% 
fetal bovine serum). After 18 h, cells were stimulated with phorbol 12-myristate-13-acetate 
(PMA, 50 ng/ml) and ionomycin (50 ng/ml) in the presence of brefeldin A (10 pig/ml) for 6 
h. Cells were harvested, washed, stained with FITC-labeled anti-CD4 (H129.19), Cychrome-
labeled anti-CD44 (IM7) or the appropriate isotype controls and fixed in paraformaldehyde. 
Intracellular cytokines were assayed as described in (17) using PE-labeled IFN-y (XMG1.2) 
or an appropriate isotype control. All antibodies were obtained from Pharmingen (San 
Diego, CA) unless stated otherwise. Cells were acquired on a FACScan flow cytometer 
(Becton Dickinson, San Jose, CA) and data were analyzed using CellQuest software (Becton 
Dickinson). 
Measurement of cytokine responses. For recall responses, 1 x 106 DLN cells were cultured in 
each well of a 96-well plate with or without 50 pig/ml of Ag in CTCM. After 3 d, 
supematants were harvested and assayed via ELISA for IFN-y; sensitivity ranged between 39 
and 156 pg/ml. To assay IL-12p40 production, 1 x 106 DLN cells were cultured in each well 
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of a 96-well plate with or without 50 ug/rnl of Ag in CTCM. After 24 hr, supernatants were 
harvested and assayed via ELIS A for IL-12p40 with sensitivity to 39 pg/ml. All ELIS A 
antibodies were purchased from Pharmingen and used according to manufacturer 
recommendations. The IL-12p40 ELISPOT protocol was adapted from Scharton-Kersten et 
al (30) and used the same pair of antibodies as used in the IL-12p40 ELISA. Briefly, 
Immulon II plates (Dynex Technologies, Chantilly, VA) were coated with antibody overnight 
at 4°C. The next day, plates were washed with sterile PBS and blocked with 5% fetal calf 
serum in PBS for 2 hours. Freshly isolated cells were added to the wells in CTCM and 
serially diluted. Leishmania Ag was added to some wells at a final concentration of 50 
[jg/ml. Plates were incubated overnight at 37°C and 5% CO2 and then washed four times in 
PBS. The secondary antibody was added overnight at 4°C, followed by extensive washing 
with Tween/PBS and PBS the next day. Plates were developed by adding an alkaline 
phosphatase conjugate for 30 min at 37°C, washing and adding the substrate 5-bromo-4-
chloro-3-indolyl phosphate (BCIP, Fisher, Hanover Park, IL) diluted to 1 mg/ml in a solution 
of 0.1 M 2-amino-2-methyl-1 -propanol (ICN Biomedicals, Aurora, OH) and 0.6% low-melt 
agarose (Fisher). Spots, which represent single IL-12p40-producing cells, were counted the 
next day using a platform microscope. 
CDllc depletion and B cell purification. CD1 lc+ cells were depleted from lymph nodes via 
magnetic positive selection using anti-CD 1 lc MicroBeads (Miltenyi Biotec, Auburn, CA) 
according to the manufacturer's protocol. Cells were subjected to two passes through an 
AutoMACS cell sorter. B cells were purified from lymph nodes via magnetic depletion 
using the MagCellect B cell isolation kit (R&D Systems, Minneapolis, MN). Cells were 
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labeled with the biotin-conjugated antibody cocktail and streptavidin solution according to 
the manufacturer's recommendations, and then subjected to two passes through an 
AutoMACS cell sorter. The purity of the CD19+ B cells was routinely 95% or greater. 
Statistical procedure. Statistical analysis was performed using Statview (SAS, Cary, NC). 
When the data were normally distributed, data were analyzed with either a Scheffe test when 
pair-wise comparisons were made between treatment groups or a paired t-test when two 
treatments within a group were compared. When data were not normally distributed, data 
were analyzed using a Mann-Whitney U test. Differences were considered significant when 
p < 0.05. 
Results 
Exogeneous administration of IL-12 promotes a Thl response in L. amazonensis-
infected mice. 
A previous study has shown that the administration of exogenous IL-12 at the time of 
L. amazonensis infection does not promote healing (17). Additional work has demonstrated 
that mice chronically infected with L. amazonensis do possess a population of Ag-responsive 
CD44hl CD4+ T cells that are unskewed towards either a Thl or Th2 phenotype in vivo but 
can enhance IFN-y production in response to IL-12 in vitro, although that enhancement is 
limited compared to CD4+ T cells from L. major-infected mice (25). To assess the extent of 
IL-12 responsiveness in vivo during L. amazonensis infection, mice were administered IL-12 
at the time of infection and then every other day after infection for two weeks in the infected 
footpad. L. major-infected mice were used as a benchmark for a productive Thl response. 
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At two weeks post-infection, the draining lymph node (DLN) was removed and cells were 
stimulated with Ag. After 24 hours, the percentage of CD44hl CD4+ T cells producing IFN-y 
from L. amazonensis-infected mice treated with IL-12 was similar to the percentage of 
CD44hl CD4+ T cells producing IFN-y from L. mq/or-infected mice (Figure 1A). The 
percentage of CD44hl CD4+ IFN-y+ T cells was significantly greater in IL-12-treated L. 
amazonensis-'mfected mice as compared to L. amazonensis-infected control mice. Similarly, 
recall responses of DLN cells showed a significant enhancement in IFN-y production from 
the L. amazonensis-infected mice treated with IL-12 compared to the controls (Figure IB). 
This increased amount of IFN-y production was similar to amounts produced by DLN cells 
from L. major-infected mice. This data indicates that exogenous IL-12 treatment at the time 
of L. amazonensis-infection is sufficient to drive a Thl response. 
L. amazonensis-infected mice treated with IL-12 do not maintain a Thl response. 
Since treatment with IL-12 has been shown not to mediate healing of L. amazonensis-
infected mice (17), we examined whether or not IL-12-treated L. amazonensis-infected mice 
sustain the Thl response that is observed at two weeks post-infection. In contrast to the two 
weeks post-infection (Figure 1A), the percent of CD44hl CD4+ T cells producing IFN-y after 
a 24-hr Ag stimulation was not significantly different between IL-12-treated and control L. 
amazonensis-infected mice at ten weeks post-infection (Figure 2A). Both of these groups 
had significantly less CD44hl CD4+ IFN-y+ T cells than the L. major-infected mice (data not 
shown and as reported in (25)). Recall responses of DLN cells at ten weeks post-infection 
showed no difference in IFN-y production between IL-12-treated and control 
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Figure 1. L. amazonensis-infected mice respond to exogenous IL-12 treatment by developing 
a Thl response. (A) DLN cells were harvested at two weeks p.i., stimulated for 24 h with 50 
pig/ml of Ag, stained with fluorescent antibodies against CD4, CD44 and IFN-y and then 
analyzed by flow cytometry as described in materials and methods. Cells from L. 
amazonensis-infected mice were stimulated with L. amazonensis Ag and cells from L. major-
infected mice were stimulated with L. major Ag. Data are represented as the mean + the 
SEM of three separate experiments. * represents a statistically significant difference from all 
other groups at p < 0.05 as determined by a Scheffe test. (B) DLN cells harvested at two 
weeks p.i. were stimulated for three days in the presence (Ag Stim) or absence (No Stim) of 
50 ^ig/ml of their respective Ag as described in (A); supernatants were assayed for IFN-y via 
ELISA. Data are represented as the mean + the SEM of four to five separate experiments for 
L. major- and L. amazonensis-infected groups, respectively. * represents a statistically 
significant difference between No Stim and Ag Stim within a group at p < 0.05 as determined 
by a Mann-Whitney U test. Ag stim groups with different superscripts are significantly 
different from one another at p < 0.05 as determined by a Mann-Whitney U test. 
L. amazonensis-infected mice (Figure 2B). DLN cells from L. major-infected mice produced 
significantly more IFN-y than either group of L. amazonensis-infected mice. Although 
treatment of L. amazonensis-infected mice with IL-12 promoted a significant reduction in 
lesion size as compared to L. amazonensis control mice in these experiments, the lesions 
were still significantly larger than those of L. major-infected mice at ten week post-infection 
(Figure 2C). The parasite burden in the infected footpad of IL-12-treated L. amazonensis-
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infected mice was not significantly different from either the L. amazonensis- or L. major-
infected mice (Figure 2D). Together, this data indicates that while L. amazonensis-\nfected 
mice do respond to exogenous IL-12 treatment by developing a Thl response early during 
infection, that response is not maintained over time and the mice fail to heal their infection to 
the same extent as L. major-infected mice. 
B cells are a source of IL-12 during chronic L. major infection but not during chronic L. 
amazonensis infection. 
IL-12 expression is necessary for the development and maintenance of a CD4+ Thl 
phenotype in vivo during L. major-infection (reviewed in (28)). Although previous work has 
demonstrated that the number of IL-12p40-producing cells present in the DLN of L. major-
infected mice is significantly greater than in L. amazonensis-'mfected mice early during 
infection (17), we found similar numbers of DLN IL-12-p40-producing cells in both L. 
amazonensis- and L. major-infected mice ex vivo at ten weeks post-infection (Figure 3A). 
Recent work has shown that Ag-specific IL-12p40 can be detected in vitro following Ag 
stimulation of DLN cells isolated from Toxoplasma gondii-infected mice (11). Upon in vitro 
Ag stimulation of DLN cells from L. major-infected mice, a significant increase in the 
number of IL-12p40-producing cells was observed compared to the unstimulated controls. In 
contrast, DLN cells from L. amazonensis-infected mice fail to increase IL-12p40 production 
in response to parasite stage-specific Ag stimulation. Similar results were obtained when 
DLN cell culture supernatants were assayed via ELISA for IL-12p40 (Table 1). Upon 
observing an Ag-specific increase in the number of IL-12p40-producing cells in the L. major 
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Figure 2. IL-12 treated L. amazonensis-infected mice do not maintain their Thl response and 
subsequently fail to heal their infection. (A) DLN cells harvested at ten weeks p.i. were 
cultured and analyzed as described in Figure 1A. Data are represented as the mean + the 
SEM of two separate experiments. (B) DLN cells harvested at ten weeks p.i. were cultured 
as described in Figure IB and supernatants were assayed for IFN-y via ELISA. Data are 
represented as the mean + the SEM of two to three separate experiments for L. major- and L. 
amazonensis-infected groups, respectively. * represents a statistically significant difference 
between No Stim and Ag Stim within a group at p < 0.05 as determined by a paired t test. 
Ag stim groups with different superscripts are significantly different from one another at p < 
0.05 as determined by a Scheffe test. (C) Lesion size in C3H mice infected with either L. 
amazonensis + IL-12 or L. major at ten weeks p.i. Individual mouse measurements are 
graphed from four experiments for a total of 13 mice per group. Long line represents the 
group mean and short lines represent the standard deviations of the mean. Groups with 
different superscripts are significantly different from one another at p < 0.05 as determined 
by a Mann-Whitney U test. (D) Parasite burden in the feet mice infected with L. 
amazonensis ± IL-12 or L. major at ten weeks post-infection. Data are represented as the 
mean + the SEM of three to four separate experiments for L. major- and L. amazonensis-
infected groups, respectively. Groups with different superscripts are significantly different 
from one another at p < 0.05 as determined by Scheffe's post-hoc test. 
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DLN cell cultures, we wished to determine the cell population responsible for this increase. 
Ag stimulation of dendritic cell-depleted DLN cell cultures from L. major-infected mice still 
resulted in a significant increase in the number of IL-12p40-producing cells (Figure 3B). 
Harris et al has demonstrated that B cells from mice infected with T. gondii produce IL-12 in 
response to in vitro Ag stimulation (11). Cultures of purified B cells from L. major-infected 
mice significantly increased the number of IL-12p40-producing cells in response to Ag 
stimulation whereas cultures of B cells from L. amazonensis-infected mice did not (Figure 
3C). Similar results were obtained when B cell culture supernatants were assayed via ELIS A 
for IL-12p40 (Table 2). These data demonstrate that B cells are a source of Ag-specific IL-
12 production during chronic L. major infection and not during chronic L. amazonensis 
infection. 
Administration of exogenous IL-12 does not promote a population of Ag-specific, IL-
12p40-producing B cells during L. amazonensis infection. 
Considering that IL-12-treated L. amazonensis-infected mice fail to maintain a Thl 
response (Figure 2), and that B cells are a source of Ag-specific IL-12 during chronic L. 
major-infection (Figure 3C), we determined if administering exogenous IL-12 to L. 
amazonensis-infected mice promoted endogenous IL-12p40 production. At two weeks post­
infection, the number of IL-12p40 producing total DLN cells was similar between IL-12-
treated L. amazonensis-infected mice and L. major-infected mice, and both groups had more 
IL-12p40-producing total DLN cells than the L. amazonensis-infected control mice (Figure 
4A). Similar results were observed when supernatants from DLN cells stimulated for 24 
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Figure 3. CD19+ B cells are a source of IL-12 during chronic L. major infection but not 
during chronic L. amazonensis infection. (A) DLN cells were harvested at ten to sixteen 
weeks post-infection and either left unstimulated or stimulated with either promastigote or 
amastigote antigen overnight; the number of IL-12p40-producing cells was determined via 
ELISPOT. Data are represented as the mean + the SEM of two separate experiments for 
uninfected mice, four experiments for L. amazonensis-infected mice and six experiments for 
L. major-infected mice. * represents a statistically significant difference between No Stim 
and either Promastigote or Amastigote Ag Stim within a group at p < 0.05 as determined by a 
paired t test. (B) CD1 lc-depleted DLN cells were harvested and assayed as in A. Data are 
represented as the mean + the SEM of two separate experiments for uninfected mice, four 
experiments for L. amazonensis-infected mice and five experiments for L. major-infected 
mice. * represents a statistically significant difference between No Stim and Amastigote Ag 
Stim within a group at p < 0.05 as determined by a paired t test. (C) Purified B cells were 
harvested and assayed as in A; number of experiments and statistical analysis are same as in 
B. 
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Table 1. IL-12p40 (in pg/ml) detected in total lymph node cell cultures 24 hours 
post-Ag stimulation 
Experiment Infection No Stim Promastigote Ag Amastigote Ag 
1 L. amazonensis 116 106 145 
L. major 159 180 292 
Uninfected 103 102 135 
2 L. amazonensis 280 211 254 
L. major 308 560 470 
Uninfected * * * 
3 L. amazonensis * * * 
L. major 145 362 277 
Uninfected 137 160 161 
4 L. amazonensis ND ND 50 
L. major 82 122 150 
Uninfected ND ND ND 
Mean difference from No Stim (p values in parentheses) 
Promastigote Ag Amastigote Ag 
L. amazonensis -26.33 5.00 
(0.346) (0.788) 
L. major 132.50 123.75 
(0.112) (0.008) 
Uninfected 7.33 18.67 
(0.448) (0.192) 
* indicates no sample 
ND indicates non-detectable; for statistical analysis, ND samples were given a value of 38 
because the detection limit of the ELISA was 39 pg/ml 
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Table 2. IL-12p40 (in pg/ml) detected in CD19+ B cell cultures 24 hours 
post-Ag stimulation 
Experiment Infection No Stim Promastigote Ag Amastigote Ag 
1 L. amazonensis 45 ND 53 
L. major ND 72 103 
Uninfected * * * 
2 L. amazonensis ND ND 45 
L. major ND 50 84 
Uninfected * ND 54 
3 L. amazonensis ND ND ND 
L. major ND 154 67 
Uninfected * * * 
4 L. amazonensis * * * 
L. major ND 186 ND 
Uninfected 75 62 49 
Mean difference from No Stim (p values in parentheses) 
Promastigote Ag Amastigote Ag 
L. amazonensis -2.33 5.00 
(0.423) (0.185) 
L. major 77.50 35.00 
(0.097) (0.085) 
Uninfected 13.00 -26.00 
NA NA 
* indicates no sample 
ND indicates non-detectable; for statistical analysis, ND samples were given a value of 38 
because the detection limit of the ELISA was 39 pg/ml 
NA indicates non-applicable because there were not enough degrees of freedom 
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hours with Ag were analyzed via ELISA for IL-12p40 (Table 3). Upon Ag stimulation, an 
increase was observed in the number of IL-12p40-producing cells compared to the 
unstimulated controls; however, this was not the case for either the IL-12-treated or the 
control L. amazonensis-infected groups. A substantial reduction in the number of IL-12p40-
producing cells was observed in all unstimulated cultures when CD1 lc+ cells were depleted, 
consistent with a successful depletion. Unlike L. major CD1 lc-depleted cultures, no increase 
in the number of IL-12p40-producing cells was observed in either the IL-12-treated or the 
control L. amazonensis cultures when stimulated with Ag (Figure 4A). Although purified B 
cells from IL-12-treated L. amazonensis-infected mice stimulated with Ag produced slightly 
more IL-12p40 than B cells from L. amazonensis-infected control mice, the amount was 
considerably less than what was produced by Ag-stimulated B cells from L. major-infected 
mice (Figure 4B). Similar results were observed when supernatants from purified B cells 
A B 
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Figure 4. Administration of exogenous IL-12 at the time of L. amazonensis infection 
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depleted cells harvested at two weeks post-infection were either left unstimulated or 
stimulated with amastigote Ag; the number of IL-12p40-producing cells was determined via 
ELISPOT. Data are from one experiment. (B) Purified B cells were cultured and assayed as 
in A. Data are from one experiment. 
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Table 3. IL-12p40 (in pg/ml) detected in total lymph node cell cultures 24 hours post-Ag 
stimulation at two weeks post-infection 
Experiment Infection No Stim Promastigote Ag Amastigote Ag 
1 L. amazonensis + IL-12 421 324 448 
L. amazonensis 101 71 130 
L. major 294 338 437 
2 L. amazonensis + IL-12 504 350 493 
L. amazonensis 96 73 95 
L. major 295 268 311 
Mean difference from No Stim (p values in parentheses) 
Promastigote Ag Amastigote Ag 
L. amazonensis + IL-12 -125.50 8.00 
(0.142) (0.746) 
L. amazonensis -26.50 14.00 
(0.084) (0.522) 
L. major 8.5 79.50 
(0.850) (0.429) 
* indicates no sample 
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Table 4. IL-12p40 (in pg/ml) detected in purified CD19+ B cell cultures 24 hours post-Ag 
stimulation at two weeks post-infection 
Experiment Infection No Stim Promastigote Ag Amastigote Ag 
1 L. amazonensis + IL-12 69 * 96 
L. amazonensis ND ND ND 
L. major ND 67 91 
2 L. amazonensis + IL-12 67 * 64 
L. amazonensis ND ND ND 
L. major ND 85 39 
Mean difference from No Stim (p values in parentheses) 
Promastigote Ag Amastigote Ag 
L. amazonensis + IL-12 * 12.00 
(0.570) 
L. amazonensis 0.00 0.00 
(NA) (NA) 
L. major 38.00 27.00 
(0.148) (0.488) 
* indicates no sample 
ND indicates non-detectable; for statistical analysis, ND samples were given a value of 38 
because the detection limit of the ELISA was 39 pg/ml 
NA indicates non-applicable because there was no variation between the data points 
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stimulated for 24 hours with Ag were analyzed via ELISA for IL-12p40 (Table 4). Together, 
this data indicates that administration of exogenous IL-12 to L. amazonensis-infected mice 
promotes enhanced IL-12 production from predominantly non-Ag-specific CD1 lc+ cells but 
does not promote Ag-specific IL-12 production from B cells at two weeks post-infection. 
At ten weeks post-infection, the number of total DLN cells producing IL-12p40 from 
IL-12-treated L. amazonensis-infected mice was similar to slightly less when compared to L. 
amazonensis-infected control mice, both in the presence and absence of Ag stimulation 
(Figure 5A). Similar results were observed when supernatants from DLN cells stimulated for 
24 hours with Ag were analyzed via ELISA for IL-12p40 (Table 5). Upon Ag stimulation of 
CD1 lc-depleted cells or purified B cells, no difference was observed in the number of IL-
12p40-producing cells between the IL-12-treated and control L. amazonensis-infected mice 
(Figures 5A & B). Moreover, significantly less IL-12p40-producing B cells were observed 
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Figure 5. Administration of exogenous IL-12 at the time of L. amazonensis infection does 
not promote a population of Ag-specific, IL-12p40-producing B cells during L. amazonensis 
infection. DLN cells, CD 1 lc-depleted (A) and purified B cells (B) were harvested at ten 
weeks post-infection and either left unstimulated or stimulated with amastigote Ag; the 
number of IL-12p40-producing cells was determined via ELISPOT. Data are from one 
experiment. 
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Table 5. IL-12p40 (in pg/ml) detected in total lymph node cell cultures 24 hours post-Ag 
stimulation at ten weeks post-infection 
Experiment Infection No Stim Promastigote Ag Amastigote Ag 
1 L. amazonensis 92 49 82 
L. major 146 103 132 
Uninfected 131 145 150 
2 L. amazonensis 192 * 178 
L. major 150 135 129 
Uninfected 127 131 142 
Mean difference from No Stim (p values in parentheses) 
Promastigote Ag Amastigote Ag 
L. amazonensis -43.00 -12.00 
(NA) (0.105) 
L. major -29.00 -17.50 
(0.286) (0.008) 
Uninfected 9.00 17.00 
(0.323) (0.075) 
* indicates no sample 
ND indicates non-detectable; for statistical analysis, ND samples were given a value of 38 
because the detection limit of the ELISA was 39 pg/ml 
NA indicates non-applicable because there were not enough degrees of freedom 
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in both IL-12-treated and control L. amazonensis cultures as compared to L. major cultures 
(Figure 5B). These data show that administering exogenous IL-12 does not promote 
sustained production of Ag-specific IL-12 production from B cells during chronic L. 
amazonensis infection. 
Discussion 
In the present study, we extend our understanding of IL-12 responsiveness during L. 
amazonensis infection. Our data demonstrate that CD4+ T cells from L. amazonensis-
infected mice do indeed respond to exogenous IL-12 administered at the time of infection by 
developing a Thl phenotype (Figure 1). However, these mice fail to heal their infections; a 
phenomenon that corresponds with an inability of these mice to maintain their Thl CD4+ T 
cell response (Figure 2). Additionally, B cells are not a source of Ag-specific IL-12 during 
chronic L. amazonensis infection (Figure 3), and administration of exogenous IL-12 fails to 
develop a population of Ag-specific IL-12 producing B cells during L. amazonensis infection 
(Figures 4 and 5). 
Our finding that B cells are a source of Ag-specific IL-12 during chronic L. major 
infection was a bit surprising, as more traditional roles for B cells have focused upon antigen 
presentation, promoting Th2 responses and antibody production. Although dendritic cells are 
considered the most potent antigen presenting cells (APCs) for capturing antigens in a non-
antigen-specific manner and presenting them to T cells in a highly immunogenic form, B 
cells can also function as APCs (4). B cells are potent APCs for primed T cells, and are most 
efficient as APCs when they present Ag bound specifically to surface Ig (slg) rather than 
when the Ag enters the cell in an slg-independent manner (27). Although much literature 
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indicates that B cells likely induce Th2 responses, a recent report indicates that B cells can 
induce the differentiation of Thl CD4+ T cells by producing IL-12 (33). Our data are 
consistent with this recent report, and suggest that B cells are an antigen-specific source of 
sustained IL-12 during chronic L. major infection. 
Conflicting reports exist on the influence of B cells on the T cell-mediated immune 
response against L. major. BALB/c mice treated with anti-IgM antibody or BALB/c X-
linked immunodeficient mice that lack BIB cells either heal or display enhanced resistance 
to L. major, respectively (12, 29), whereas other work concludes that anti-IgM-treated 
BALB/c mice remain susceptible (3). Additionally, a report by Babai et al showed that 
depletion of peritoneal CD5+ B cells had no effect on the outcome of L. major infection in 
both resistance and susceptible mouse strains (2). Work by Scott et al demonstrated that 
resistant C3H mice treated with anti-IgM were unable to heal their L. major infections, which 
remained chronic but non-progressive (32). Adoptive transfer of immune T cells into IgM-
depleted mice restored their ability to heal, suggesting that the T cells required for healing a 
L. major infection depend upon B cells for their development. This concept is supported by 
additional work demonstrating that B cells are required for a delayed type hypersensitivity 
(DTH) memory response in C57BL/6 mice (6). Our results indicate that B cells may 
contribute to the Thl CD4+ T cell memory response present in L. major-infected mice by 
functioning as a source of antigen-specific IL-12 in resistant mouse strains. 
In contrast to infection with L. major, a more exact role for B cells has been described 
during infection with members of the L. mexicana complex, including L. amazonensis and L. 
pifanoi. In the absence of circulating antibody, infection of L. mexicana complex parasites 
cannot be maintained because the parasites are not internalized into macrophages via the Fc 
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receptor (5, 18). These studies have established a critical role for antibody in the 
pathogenesis of cutaneous leishmaniasis caused by these parasites. Additional work has 
shown that B cells appear to regulate L. donovani infection independently of antibody as B 
cell-deficient mice are resistant to infection but develop destructive hepatic pathology 
mediated by neutrophils (34). 
IL-12 was originally identified as a product of human Epstein-Barr virus-transformed 
B cell lines (19). For many years, murine B cells were thought incapable of producing IL-12 
until recent reports demonstrated this ability in both B cells from infected mice or B cells 
stimulated with CpG oligodeoxynucleotides in vitro (8, 11, 23, 33). In a model originally 
proposed by Mamula and Janeway, B cells are important for amplifying and maintaining T 
cell responses initiated by dendritic cells (22). These activated T cells migrate to the outer T 
cell zone (21) and then to the B cell area (7) where they interact with Ag-specific B cells and 
a massive expansion of both T and B cells ensues (9, 20). When B cells encounter IFN-y-
producing T cells expressing CD40L, they produce IL-12, further reinforcing IFN-y 
production by adjacent IL-12-responsive T cells (31). Work by Wagner et al demonstrates 
that IL-12 production from human B cells is also under the control of both microbial 
stimulation, indicating that B cells only produce IL-12 when they simultaneously encounter 
T cells and sense the appropriate microbial molecule, such as CpG (39). Based on this 
model, the failure of L. amazonensis-infected mice to develop a population of IL-12p40-
producing B cells may correlate with the inability of these mice to sustain their Thl response. 
In summary, CD4+ T cells are able to respond to IL-12 in vivo by developing a Thl 
response early during L. amazonensis infection. However, these mice do not maintain that 
Thl response over time and subsequently fail to heal their infections. Additionally, B cells 
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are not a source of antigen-specific IL-12 during chronic L. amazonensis infection, a defect 
not overcome by the administration of exogenous IL-12. Together, these data implicate a B 
cell population defective in IL-12 production as a potential mechanism contributing to the 
chronicity of L. amazonensis infection. 
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Chapter 5 
Conclusions 
Summary 
The work presented in this dissertation demonstrates that infection with L. 
amazonensis creates a population of antigen-responsive, CD44hl CD4+ T cells that proliferate 
and produce IL-2 but do not polarize to an effector phenotype. While these T cells are able 
to enhance IFN-y production in response to IL-12, the amount of IFN-y produced is only 10-
15% of that produced in L. major CD4+ T cell cultures. These data demonstrate that the 
failure of CD4+ T cells from L. amazonensis-infected mice to become efficient Thl effector 
cells is due to factors beyond the presence or absence of IL-12. 
Additional analysis of the IL-12 responsiveness of this T cell population indicates that 
IL-2 may be one of the factors involved in limiting the immune response during L. 
amazonensis infection as it limits enhanced proliferation of CD44hl CD4+ T cells in response 
to IL-12. Providing multiple Ag stimulations in the presence of IL-12 yields equivalent 
percentages of IFN-y-producing CD44hl CD4+ T cells in cultures of T cells from both L. 
amazonensis- and L. major-infected mice. However, the total amount of IFN-y produced by 
T cells isolated from L. amazonensis-infected mice is 40% less than that produced by CD4+ T 
cells from L. major-infected mice; a deficit resulting, at least in part, from a failure of CD44hl 
CD4+ T cells from L. amazonensis-infected mice to accumulate in culture. In contrast to 
CD44hl CD4+ T cells from L. major-infected mice, CD44hl CD4+ T cells from L. 
amazonensis-infected mice are less responsive to both IL-2 and IL-12 for enhancing 
proliferation. However, neutralization of IL-2 allows enhanced proliferation of CD44hl CD4+ 
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T cells from L. amazonensis-infected mice in response to IL-12. Following multiple Ag 
stimulations, CD44hl CD4+ T cells from L. amazonensis-infected mice sustain a higher 
expression of CD25 than do CD44hl CD4+ T cells from L. major-infected mice, a phenotype 
regulated by IL-2 and consistent with that of regulatory T (Treg) cells. Together, these results 
indicate that IL-2 suppresses enhanced proliferation in response to IL-12 for CD4+ T cells 
from L. amazonensis-infected mice. 
To recapitulate continual culture of CD4+ T cells with IL-12 in vivo, multiple doses 
of IL-12 were administered to mice during the first two weeks of L. amazonensis infection. 
Although CD4+ T cells respond to exogenous IL-12 administered during L. amazonensis 
infection by developing a Thl phenotype at two weeks post-infection, that response is not 
maintained and the mice fail to heal their infections. IL-12 treatment also fails to promote a 
sustained source of antigen-specific IL-12 from B cells in these mice. These data indicate 
that the failure of IL-12-treated L. amazonensis-infected mice to heal their infection is not 
due to an inability to mount a Thl response, but rather from a lack of sustained, antigen-
specific IL-12 production from B cells. 
Discussion 
The immune response to L. major 
A protective immune response against L. major consists of a CD4+ T cell population 
that produces IFN-y and responds to IL-12, thereby promoting a Thl response. Early after 
infection, dendritic cells are the primary source of IL-12 (7, 8, 11, 16). Leishmania-infected 
macrophages are inhibited in their ability to make IL-12 in response to additional stimuli, and 
therefore contribute very little to IL-12 production during L. major infection (2). IFN-y-
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producing, T-bet+ CD4+ Thl cells are able to effectively activate macrophages at the site of 
lesion development to kill the intracellular amastigotes in a nitric oxide-dependent manner 
(reviewed in (12)). Not only is the development of this Thl response dependent upon IL-12, 
its maintenance is as well (10, 14). Our data extend the knowledge of cellular sources of IL-
12 by demonstrating that Ag-specific B cells produce IL-12 during the later stage of L. major 
infection. Ultimately, the productive Thl response generated during L. major infection leads 
to lesion resolution and a very small parasite load (less than 100 parasites per infected 
footpad). Additionally, a population of CD4+ CD25+ Treg cells develops during L. major 
infection, and is necessary for the establishment of chronic L. major infection and the 
accompanying low parasite load. Furthermore, the functions of this Treg population are 
dependent upon IL-10 (1). A productive memory CD4+ T cell response has also been shown 
to develop following L. major infection (17). 
The model presented in Figure 1 demonstrates the maturation of the productive 
immune response during L. major infection described above. During L. major infection, 
dendritic cells are appropriately activated in the presence of a sufficient amount of 
inflammatory mediators including IL-12. In turn, these DCs efficiently prime a population of 
Thl CD4+ effector/memory T cells that promote the resolution of antigen load by activating 
macrophages to kill the parasite. This decrease in parasite load subsequently facilitates a 
reduction in the inflammatory response associated with infection. At the beginning of the 
immune response, early-activated CD4+ T cells are likely sources of IL-2. As inflammation 
increases, the predominant cytokine produced becomes IL-12, which promotes the early-
activated CD4+ T cell population to differentiate into more mature effector T cells. 
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Figure 1. Summary of the maturation of the immune response to L. major. The healing 
immune response to L. major is characterized by a CD4+ T cell population that can resolve 
antigen load in the context of an appropriate amount of inflammation. Ultimately, a chronic 
host-parasite relationship develops with low amounts of antigen and inflammation, as do 
populations of regulatory T cells and memory T cells. The maintenance of the Thl response 
to L. major requires a sustained source of IL-12. 
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These mature CD4+ T cells are able to reduce antigen load, which perpetuates a decrease in 
inflammation including IL-12 production. However, low amounts of IL-12 continue to be 
important for memory Thl cell maintenance during the later stage of the immune response. 
The immune response to L. amazonensis 
In contrast to the productive immune response to L. major, the host immune response 
to L. amazonensis does not facilitate healing and instead promotes a state of chronic disease 
characterized by a high parasite burden. Work from our laboratory indicates that the immune 
mechanisms required to kill L. amazonensis amastigotes are more rigorous than those for L. 
major amastigotes, and that appropriate B cell and CD4+ T cell responses are also necessary 
for effective clearance of L. amazonensis (9). The data presented in this thesis describe 
numerous defects in the CD4+ T cell population during L. amazonensis in terms of 
accumulation and IL-12 responsiveness. This work also reports a B cell population defective 
in IL-12 production during L. amazonensis infection. We believe that these cellular defects 
cause inefficient parasite killing during L. amazonensis infection thus creating a persistent 
antigen environment. 
L. amazonensis infection may also create a semi-mature dendritic cell population in 
vivo. Our laboratory has shown that in vitro infection of bone-marrow derived dendritic cells 
(BMDCs) with L. amazonensis amastigotes enhances surface expression of MHC II and the 
costimulatory molecules CD80 and CD86 but not CD40; these DCs also produce less IL-12 
than those infected with L. major (5). Indeed, others have described decreased IL-12 
production during L. amazonensis infection as well as decreased mRNA expression of other 
multiple inflammatory mediators (4, 6, 15). All these factors likely contribute to the 
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inappropriate maturation and priming of DCs during L. amazonensis infection. Recent work 
has shown that inappropriately primed dendritic cells in vivo can support CD4+ T cell clonal 
expansion but cannot prime an effector response (13); the data presented in this dissertation 
describes a similar CD4+ T cell response during L. amazonensis infection. Based on our 
data, we hypothesize that the high antigen load present during L. amazonensis infection 
results in continual antigen stimulation of CD4+ T cells by inappropriately primed DCs. 
These early-activated CD4+ T cells produce high amounts of IL-2, which in turn limits the 
maturation and differentiation of the cellular immune response by limiting expansion of IL-
12-responsive CD4+ T cells. Although administration of exogenous IL-12 during L. 
amazonensis infection promotes the development of an effector CD4+ T cell response, this 
population of cells fails to eliminate parasites and perpetuate healing; upon removal of IL-12, 
the Thl response is not maintained and the CD4+ T cell response returns to an unpolarized 
one. Our in vitro results indicate that IL-2 limits the survival and accumulation of the CD4+ 
Thl cell population, and in the absence of a sustained source of IL-12, the Thl response is 
not maintained. Indeed, we believe IL-2 may promote the development of an antigen-
specific regulatory T cell population that prevents the subsequent differentiation of 
neighboring CD4+ T cells to effector cells. 
Administration of exogenous IL-12 at the time of L. amazonensis infection also fails 
to promote a population of antigen-specific IL-12-producing B cells. We propose that the B 
cells present during L. amazonensis infection fail to mature to a population that produces IL-
12 and secretes a predominance of IgG2a antibodies, the isotype of antibody associated with 
a Thl response. Should a productive B cell response be present during L. amazonensis 
infection, we hypothesize that IgG2a antibodies would bind Fey receptor II on infected 
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macrophages and activate the intracellular signaling cascades necessary for superoxide 
production. Superoxide would then combine with nitric oxide to produce peroxynitrite, a 
potent cytotoxic factor, to mediate killing of L. amazonensis. Together, defective CD4+ T 
cell and B cell responses preclude the cellular immune response from maturing and resolving 
a L. amazonensis infection (Figure 2). 
We believe the immune response associated with L. amazonensis infection is 
consistent with the theoretical model of cellular self-renewal and differentiation proposed by 
Grossman and colleagues (3). In this model, self-renewal and differentiation are competing 
cellular events regulated by both antigen/APC interactions and cytokines. Antigen load 
influences whether or not a cell is activated or resting; if antigen is presented by APCs in the 
context of an inflammatory milieu, then a cell becomes activated. Cytokines can 
subsequently influence whether or not the cell differentiates or self-renews. Presumably, in a 
resolving antigen environment and the presence of polarizing cytokines, including IL-4 and 
IFN-y, the CD4+ T cell differentiates towards a Thl or Th2 effector phenotype. If cytokines 
such as IL-10 or TGF-(3 are present, a cell may differentiate towards a regulatory phenotype. 
In contrast, persistent antigen causes T cells to adapt to a higher threshold for activation; 
these cells will self-renew rather than differentiate. We propose that repeated antigen 
stimulation and IL-2 are preventing the CD4+ T cells present during L. amazonensis infection 
from differentiating into a more mature effector cell population and is instead holding them 
in a pattern of self-renewal (Figure 3). This immature CD4+ T cell phenotype continues to 
perpetuate the persistent antigen environment by inefficiently activating macrophages to kill 
the parasites, which ultimately creates a cycle of inadequate activation and high antigen load. 
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Figure 2. Summary of the immune response to L. amazonensis. The dysfunctional immune 
response to L. amazonensis is characterized by early-activated CD4+ T cells and immature B 
cells that cannot resolve antigen load. Low amounts of inflammatory signals, including IL-
12, are present during infection. The CD4+ T cells fail to differentiate into an efficient Thl 
population, receive repeated antigen stimulations due to the high antigen load, and 
subsequently produce IL-2. When exogenous IL-12 is present, a Thl response develops but 
is not maintained, presumably because IL-2 limits the accumulation and survival of Thl 
CD4+ T cells. 
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Figure 3. Model for self-renewal versus differentiation applied to Leishmania infection. 
Teal circle, arrows and text denote phenotype of CD4+ T cells during L. major infection. 
Pink circle, arrows and text denote phenotype of CD4+ T cells during L. amazonensis 
infection. CD4+ T cells from both L. amazonensis- and L. major-infected mice transition 
between a resting and activated phenotype upon antigen stimulation. The probability of 
whether or not a CD4+ T cell will self-renew or differentiate is influenced by persistent or 
resolving antigen load and the presence of inflammatory signals, including IL-12. See page 
25 for original figure legend. Modified and reprinted by permission from Macmillian 
Publishers Ltd: Nature Reviews Immunology, Grossman, Z. et al. 4(5): 387-95, copyright 
2004. 
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Recommendations for future studies 
The long-term goal of the research presented in this dissertation is to understand how 
an adaptive tolerance environment develops and is regulated during L. amazonensis 
infection. Additional experiments are needed to more clearly demonstrate that the immune 
response present during chronic L. amazonensis infection is consistent with mechanisms of 
adaptive tolerance. Continued use of the mini-double culture system is recommended to 
determine if the CD4+ CD25+ T cell population present in cultures of T cells from L. 
amazonensis-infected mice does indeed regulate the Ag-responsiveness of CD4+ CD25" T 
cells. The CD25+ CD44hl CD4+ T cells from L. amazonensis-mfected mice should also be 
evaluated for expression of additional markers associated with adaptively tolerant phenotypes 
such as PD-1 and 0X40. Additional studies should also focus upon assessing IL-2 
production during L. amazonensis infection, as well as determining if the CD25+ CD44hl 
CD4+ activated effector T cells observed following multiple in vitro Ag stimulations exist in 
vivo during infection. Studies in which L. amazonensis-infected mice are treated with anti-
IL-2 plus IL-12 would be beneficial to understanding if our observations of IL-2 limiting IL-
12 responsiveness in vitro are true in vivo. To more thoroughly establish the role of 
persistent Ag as promoting the dysfunctional CD4+ T cell response present during L. 
amazonensis infection, studies in which mice are treated with anti-leishmanial drugs at the 
time of infection are warranted. In turn, the effector phenotype of the CD4+ T cells isolated 
from these mice could then be evaluated using the mini-double culture system to determine if 
effector functions are restored. By better understanding the dysfunctional immune response 
associated with L. amazonensis infection, the potential exists to develop new therapeutic 
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strategies and novel vaccines that will aid in the fight not only against leishmaniasis but also 
against the many other chronic diseases that burden our world. 
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Appendix 
Use of Staphylococcal enterotoxin B to study the interactions of antigen 
presenting cells and CD4+ T cells during Leishmania amazonensis infection 
Introduction 
Dendritic cells (DCs) are the most efficient antigen presenting cells (APCs) in vivo. 
DCs act as a link between the innate and adaptive branches of the immune system by 
recognizing specific molecular patterns on the surface of pathogens and subsequently 
priming antigen-specific naïve T cells (1). During this priming process, DCs also influence 
the phenotype of the responding T cell population. For instance, DCs that are producing IL-
12 promote a Thl phenotype in the T cells they prime (6). DCs that are indirectly activated 
by inflammatory mediators and do not come in contact with pathogen components prime a T 
cell population that proliferates but does not differentiate to either a Thl or Th2 phenotype 
(9). We believe that the dysfunctional CD4+ T cell response observed during L. amazonensis 
infection results, in part, from priming by an improperly matured DC population (7). To 
further understand the interactions between DCs and T cells during L. amazonensis infection, 
we activated naïve T cells in the presence of an APC population derived from either L. 
amazonensis- or L. major-infected mice using Staphylococcal enterotoxin B (SEB) and 
assessed T cell effector functions. SEB is a powerful superantigen; the ability of T cells to 
respond to SEB requires that the toxin first bind to the MHC II molecule on the surface of an 
APC (5). Furthermore, only T cells bearing a certain V|3 structure in their TCR (primarily 
the V|38 chain of the TCR) are able to respond to the combination of toxin and MHC II. 
Additionally, only naïve T cells respond to stimulation with SEB (4). 
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Results and discussion 
Previous work indicates that V|3 8-bearing T cells are not present in certain inbred 
mouse strains due either to a gene deletion or the presence of an endogenous retrovirus (2, 3). 
To determine if C3H mice possess T cells bearing the V|38 TCR, draining lymph node (DLN) 
cells were harvested from mice infected with either L. amazonensis or L. major for four 
weeks or from age-matched uninfected control mice and stained with fluorescent antibodies 
for CD4, V(38.1/8.2 (clone MR5-2) and V(38.3 (clone 1B3.3) and analyzed via flow 
cytometry. Similar percentages of CD4+ T cells bearing the V(38.1/8.2 isoforms of the TCR 
were observed among L. amazonensis- and L. major-infected and uninfected mice, indicating 
that C3H mice do indeed possess CD4+ T cells bearing the V|38 TCR, and that Leishmania 
infection does not promote selection or deletion of this particular subset of T cells (Figure 1). 
Similar results were observed for the V(38.3 isoform of the TCR. 
Our laboratory has shown that L. amazonensis-infected mice possess a population of 
antigen-responsive CD44hl CD4+ T cells that produce IL-2 and proliferate upon antigen (Ag) 
stimulation but are limited in their ability to produce effector cytokines, including IFN-y (7). 
We wished to determine if naïve T cells stimulated in vitro with SEB recapitulate the 
phenotype observed for Ag-responsive T cells. DLN cells were harvested from mice infected 
with either L. amazonensis or L. major for four weeks or from age-matched uninfected 
control mice and labeled with CFSE as previously described (7). One million DLN cells 
were plated per well of a 96 well plate and stimulated with 1 iig/ml SEB (Toxin Technology, 
Sarasota, FL) for four days. Cells were harvested, stained with fluorescent antibodies for 
CD4 and CD44 and analyzed via flow cytometry as previously described (7). As observed 
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Figure 1. Similar percentages of CD4+ T cells bearing the V(38 TCR among L. amazonensis-
and L. major-infected and uninfected C3H mice. DLN cells were harvested at four weeks 
post-infection and stained with fluorescent antibodies against CD4, V(38.1/8.2 and V|38.3 and 
analyzed via flow cytometry. Histograms are based on live CD4+ T cell gates and are from 
one experiment. 
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in the Ag stimulation experiments, similar percentages of the total CD44hl CD4+ T cells 
present in culture from the L. amazonensis- and the L. major-infected mice proliferated in 
response to SEB stimulation (Figure 2). Although not statistically significantly, a trend for 
enhanced proliferation was observed for CD44hl CD4+ T cells from both L. amazonensis- and 
L. major-infected mice over CD44hl CD4+ T cells from uninfected mice (p = 0.063 and p = 
0.062, respectively). 
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Figure 2. CD44hl CD4+ T cells from L. amazonensis-infected mice proliferate similarly to 
CD44hl CD4+ T cells from L. major-infected mice in response to SEB stimulation. DLN 
cells were harvested from mice infected with either L. amazonensis or L. major for four 
weeks or from age-matched uninfected control mice, labeled with CFSE, and cultured in the 
presence or absence of SEB for four days. Cells were harvested, stained with fluorescent 
antibodies for CD4 and CD44 and analyzed via flow cytometry. Data are represented as the 
mean + the SEM of two separate experiments. Means for SEB stimulation were compared 
among groups using Scheffe's post-hoc test. 
158 
To determine if naïve CD4+ T cells stimulated with SEB in the presence of APCs 
from L. amazonensis-infected mice demonstrate defects in IFN-y production, DLN cells were 
harvested from mice infected with either L. amazonensis or L. major for four weeks or from 
age-matched uninfected control mice and stimulated with 1 |ig/ml SEB for three days. 
Culture supernatants were harvested and assayed for IFN-y via ELISA as previously 
described (7). The IFN-y produced by DLN cells from L. amazonensis-infected mice upon 
SEB stimulation was found to be only 39% of that produced by cells from L. major-infected 
mice (p = 0.133, Figure 3). Although not statistically significant, a trend for increased IFN-y 
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Figure 3. Less IFN-y produced by CD4+ T cells from L. amazonensis-infected mice 
following SEB stimulation as compared to CD4+ T cells from L. major-infected mice. DLN 
cells were harvested from mice infected with either L. amazonensis or L. major for four 
weeks or from age-matched uninfected control mice and cultured in the presence or absence 
of SEB for three days. Culture supernatants were harvested and assayed for IFN-y via 
ELISA. Data are represented as the mean + the SEM of three separate experiments. Means 
for SEB stimulation were compared among groups using Scheffe's post-hoc test. 
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production from DLN cells from L. major-infected over uninfected mice was observed (p = 
.059); however, no difference in IFN-y production was observed between DLN cells from L. 
amazonensis-infected and uninfected mice (p = 0.698). These preliminary observations 
indicate that naïve CD4+ T cells stimulated in the presence of SEB and APCs from the DLN 
of L. amazonensis-infected mice recapitulate the defect in IFN-y production that is observed 
in Ag-responsive CD4+ T cells from L. amazonensis-infected mice. More studies looking 
specifically at both IFN-y production and proliferation specifically from the V|38 CD4+ T cell 
population following SEB stimulation are warranted. 
These preliminary experiments suggest that the DLN environment present during L. 
amazonensis infection is not conducive for APCs to effectively prime a naïve T cell 
population towards a Thl phenotype. Instead, the APCs present in the DLN during L. 
amazonensis infection give rise to a T cell population limited in its effector functions—a 
scenario reminiscent of adaptive tolerance (8), which suggests that the DLN environment 
during L. amazonensis-inïection is a tolerizing one. In summary, the culture system 
described here will be a useful tool for studying the transition of CD4+ T cells from a naïve to 
effector phenotype in an environment that promotes T cell proliferation but not 
differentiation. 
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